US8753668B2 - Production of beta-glucans and mannans - Google Patents
Production of beta-glucans and mannans Download PDFInfo
- Publication number
- US8753668B2 US8753668B2 US12/693,164 US69316410A US8753668B2 US 8753668 B2 US8753668 B2 US 8753668B2 US 69316410 A US69316410 A US 69316410A US 8753668 B2 US8753668 B2 US 8753668B2
- Authority
- US
- United States
- Prior art keywords
- glucan
- yeast
- mannan
- enriched
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/14—Pretreatment of feeding-stuffs with enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
- A23L29/271—Curdlan; beta-1-3 glucan; Polysaccharides produced by agrobacterium or alcaligenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0087—Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Definitions
- the D-glucose units may be linked together in a variety of ways.
- glucans with (1,3), (1,4), (1,6) and (1,2) linkages are all known.
- the variety of linkages possible means that glucans are normally highly branched compounds. Many forms are possible as a result of this highly variable manner in which this individual glucose units can be joined as well as the overall steric shape of the parent molecule.
- a common glucan is ⁇ -(1,3)-linked glucopyranose (commonly referred to as ⁇ -glucan).
- Cell walls of several species include ⁇ -(1,3)-linked glucopyranose coupled with ⁇ -(1,6)-linked glucopyranose.
- the cell wall of Saccharaomyces cerevisiae is primarily composed of ⁇ -linked glucan, which is mainly a backbone of ⁇ -(1-3)-linked glucose units, with a minor component of inter and intra molecular branching via ⁇ -(1-6)-linkages.
- glucans Because of their chemical properties, glucans have found a wide variety of uses in the chemical, food and pharmaceutical industries. For example, they may be useful as viscosity imparting agents, emulsifiers, fibers, films, coating substances, supports for affinity chromatography and gel electrophoresis, in cell culture media, as filter pads, and in cement. They are also widely used as food thickeners and as a source of dietary fiber, and as carriers and coating agents in pharmaceutical products. Glucans have been shown to have immunopharmacological activity in humans and animals. For example, strong immunostimulation and protection against pathogenic microorganisms have been demonstrated in shrimp, fish, poultry, swine, cattle, rabbits, mice, rats and humans.
- Yeast ⁇ -glucans may stimulate the innate (non-specific) immune response of vertebrates and invertebrates via interaction with the Toll-like receptor Dectin-1. Such binding stimulates the production of active oxygen species in macrophages and enhances their phagocytosis and killing of microorganisms. These stimulated immune cells also produce cytokins which can circulate throughout the animal and interact with other immune cells to enhance the immune status of the animal.
- Mannan-oligosaccharides can be released from yeast cell walls by proteolytic action.
- the released MOS can effectively bind to bacterial pathogens of the intestinal tract and block their ability to colonize the intestinal tract.
- E. coli, Salmonella spp. and Vibrio cholera have proteins on their surface (lectins) which bind specifically to the mannose sugar residues of the MOS.
- FIG. 1 is a flowchart of one embodiment of a process for production of ⁇ -glucan/mannan preparations in accordance with the present invention.
- FIG. 2 is a flowchart of another embodiment for process for production of ⁇ -glucan/mannan preparations in accordance with the present invention.
- the present invention provides a method for processing yeast cells using the steps of autolyzing the yeast cells to release yeast cell walls, incubating the yeast cell walls with an exogenous protease, separating the yeast cell walls into a glucan-enriched component and a mannan enriched component, and ultrafiltering the mannan-enriched component to form a filtrate and a retentate.
- the invention provides a method for processing yeast cells using the steps of autolyzing the yeast cells at a temperature of 40° C. to 65° C. to release yeast cell walls, incubating the yeast cell walls with an exogenous protease at a pH of 9 to 10, and incubating the protease-treated cell walls with an enzyme such as an amylase, lipase or a combination thereof.
- the invention provides a composition comprising ⁇ -mannans, wherein at least 85% (w/w) of the total ⁇ -mannans have a molecular weight of 10,000 Da or more.
- inventions include animal feeds, food supplements, pharmaceuticals, cosmetics and neutraceuticals that comprise glucans or mannans made by methods of the invention.
- the invention provides a process that produces insoluble cell wall preparations enriched in ⁇ (1,3) and ⁇ (1,6) glucans and a soluble fraction enriched in mannans.
- the process in accordance with the present invention includes an autolysis step of a source of cell walls, for example, yeast, such as brewer's yeast or baker's yeast, followed by an enzymatic digestion step.
- the enzymatic digestion is carried out using a high-pH protease.
- the enzymatic digestion is carried out using a combination of enzymes, such as a high-pH protease, an amylase, glucoamylase and/or lipase.
- the enzymatic digestion is carried out using a high-pH protease followed by one or more other enzymes, such as amylase, glucoamylase and/or lipase.
- the invention provides a cell wall preparation that is enriched ⁇ -(1,3) and ⁇ -(1,6) glucans, and in another embodiment, a soluble fraction enriched in mannans.
- any numerical range recited herein includes all values from the lower value to the upper value. For example, if a concentration range is stated as 1% to 50%, it is intended that values such as 2% to 40%, 10% to 30%, or 1% to 3%, etc., are expressly enumerated in this specification. These are only examples of what is specifically intended, and all possible combinations of numerical values between the lowest value and the highest value enumerated are to be considered to be expressly stated in this application.
- ⁇ -glucan/mannan preparations can be prepared from microorganisms, such as yeast, using a simple autolysis process, at slightly acidic/near-neutral pH and only moderately elevated temperature. Autolysis is followed by an enzymatic digestion.
- the enzymatic step utilizes a high pH protease (e.g., Protex 6L available from Genencore International or from fermentation of Bacillus lichenformis ), typically about 0.05%-1% by weight, at an alkaline pH, and elevated temperature.
- a high pH protease e.g., Protex 6L available from Genencore International or from fermentation of Bacillus lichenformis
- Suitable yeast species as a source of ⁇ -glucans/mannans include, but are not limited to, yeast strains of Saccharomyces cerevisiae (including baker's yeast strains and brewer's yeast strains), Kluyveromyces fragilis , and Candida strains, such as Candida utilis , and combinations thereof.
- yeast strains of yeast which are suitable sources of ⁇ -glucans/mannans include, but are not limited to, Saccharomyces delbruekii, Saccharomyces rosei, Saccharomyces microellipsodes, Saccharomyces carlsbergensis, Schizosaccharomyces pombe, Kluyveromyces lactis, Kluyveromyces polysporus, Candida albicans, Candida cloacae, Candida tropicalis, Candida guilliermondii, Hansenula wingei, Hansenula arni, Hansenula henricii, Hansenula Americana and combinations thereof. These yeast strains can be produced using culture in food grade nutrients either by batch fermentation or continuous fermentation.
- microorganisms including, but are not limited to, bacteria, fungi, and plants, for example, unicellular algae, have been reported in the art as a source of ⁇ -glucans/mannans.
- Other microorganisms which may be useful in the invention as sources of ⁇ -glucans and/or mannans include, but are not limited to, bacteria, such as Alkaligenes , especially Alkaligenes faecalis Var.
- Non-microorganisms such as plants, may also be useful in the invention as sources of ⁇ -glucans and/or mannans.
- the process in accordance to the present invention relates to the generation of cell wall preparations enriched in ⁇ -(1,3)-and ⁇ -(1,6)-glucan content and mannan content, produced from microorganisms including, but not limited to, yeast.
- the process includes a first step of autolysis of yeast, e.g., brewer's yeast, (typically a 7% to 18%, particularly a 10% to 17%, and more particularly a 8% to 12% or 13% to 16% solids slurry).
- the autolysis may suitably be carried out at a pH of at least 4, particularly at least 4.5, and more particularly at least 5.
- the autolysis may suitably be carried out at a pH of less than 8, particularly less than 7, and even more particularly less than 6.
- the temperature for carrying out the autolysis may suitably be at least 30° C., particularly at least 35° C., more particularly at least 40° C., and even more particularly at least 45° C.
- the temperature for carrying out the autolysis may suitably be less than 55° C., particularly less than 52° C., and even more particularly less than 50° C.
- the autolysis may suitably be carried out for at least 10 hours, particularly at least 16 hours, and more particularly at least 24 hours.
- the autolysis may suitably be carried out for less than 100 hours, particularly less than 48 hours, and even more particularly less than 36 hours.
- the yeast is then separated, suitably by centrifugation, to produce an extract, and a cell wall stream of low ⁇ -glucan content.
- a further step treats the cell wall stream with an enzyme including, but not limited to, a protease, e.g., an alkaline protease, at a pH of at least 8.5, particularly at least 9, and more particularly at least 9.2.
- the pH may also suitably be less than 10.5, particularly less than 10, and even more particularly less than 9.8.
- the protease treatment may suitably be carried out at a temperature of at least 45° C., particularly at least 50° C., more particularly at least 53° C.
- the protease treatment may suitably be carried out at a temperature of less than 70° C., particularly less than 65° C., more particularly less than 60° C., and even more particularly less than 57° C.
- the protease treatment may be suitably carried out for at least 5 hours, particularly at least 8 hours, more particularly at least 10 hours, even more particularly at least 12 hours.
- the protease treatment may be suitably carried out for less than 48 hours, particularly less than 36 hours, more particularly less than 24 hours, and even more particularly less than 18 hours.
- the second product is then separated by centrifugation to produce an extract enriched with mannan ( ⁇ -mannan), and a cell wall product enriched in ⁇ -glucan.
- This ⁇ -(1,3/1,6) cell wall product is then dried, e.g., spray dried, which results in aggregation of the product to particles of about 100-300 microns or larger.
- the mannan extract is then subjected to a 10,000 molecular weight ultrafiltration to yield a high-molecular weight retentate that is enriched in mannan.
- Live yeast are subjected to autolysis in a process in which endogenous yeast enzymes break down and solubilize some yeast macromolecules.
- Soluble extract is separated from insoluble yeast cell walls by centrifugation.
- the cell walls are then treated with a high-pH protease to further remove protein from the cell walls, and subsequently also remove the mannan which is attached to the cell wall protein.
- the ⁇ -glucan enriched cell walls are then separated from the secondary extract by centrifugation. Mannan, which has a high molecular weight, can be further purified and concentrated by passing the secondary extract through a 10,000 Da ultrafilter.
- the process includes a first step of autolysis of yeast, e.g., brewer's yeast, (typically a 8%-12% solids slurry).
- the autolysis is suitably carried out at a pH of at least 4, particularly at least 4.5, and more particularly at least 5.
- the pH may also suitably be less than 8, particularly less than 7, and even more particularly less than 6.
- the temperature for carrying out the autolysis may suitably be at least of at least 30° C., particularly at least 40° C., and more particularly at least 45° C.
- the temperature may also suitably be less than 55° C., particularly less than 53° C., and even more particularly less than 50° C.
- the autolysis may suitably be carried out for at least 10 hours, particularly at least 16 hours, and more particularly at least 24 hours.
- the autolysis may suitably be carried out for less than 100 hours, particularly less than 48 hours, and even more particularly less than 36 hours.
- the yeast is then separated, suitably by centrifugation, to produce an extract, and a cell wall stream of low ⁇ -glucan content.
- a further step treats the cell wall stream with enzymes.
- the enzymatic step utilizes first a high pH protease at an alkaline pH, for example, at a pH of at least 8.5, particularly at least 9, and more particularly at least 9.2.
- the pH may also suitably be less than 10.5, particularly less than 10, and even more particularly less than 9.8.
- the protease treatment may suitably be carried out at a temperature of at least 45° C., particularly at least 50° C., more particularly at least 53° C.
- the protease treatment may suitably be carried out at a temperature of less than 70° C., particularly less than 65° C., and more particularly less than 60° C., and even more particularly less than 57° C.
- the protease treatment may be suitably carried out for at least 5 hours, particularly at least 8 hours, more particularly at least 10 hours, even more particularly at least 12 hours.
- the protease treatment may be suitably carried out for less than 48 hours, particularly less than 36 hours, more particularly less than 24 hours, and even more particularly less than 18 hours.
- the protease enzymatic step is followed by incubation with glucoamylase (e.g. from Aspergillus species), an amylase (e.g., ⁇ -amylases from Bacillus subtili, Aspergillus oryzae; amyloglucosidases from Aspergillus niger or Rhizopus mold) and/or a lipase (e.g., lipase from Pseudomonas cepacia, Candida rugosa and Mucor javanicus; typically about 0.05%-1% by weight),
- glucoamylase e.g. from Aspergillus species
- an amylase e.g., ⁇ -amylases from Bacillus subtili, Aspergillus oryzae; amyloglucosidases from Aspergillus niger or Rhizopus mold
- a lipase e.g., lipase from Pseu
- Temperatures of at least 60° C., at least 65° C., at least 70° C., at least 75° C., at least 80° C., at least 85° C., or at least 90° C. may be suitably be used, particularly if the protease, amylase or lipase is a thermostable enzyme.
- the incubation with the alkaline protease can also be followed by incubation with a combination of a glucoamylase and a lipase, a combination of an amylase and a lipase or a combination of a glucoamylase, an amylase and a lipase.
- live yeast are subjected to autolysis in a process where endogenous yeast enzymes break down and solubilize some yeast macromolecules.
- the cell walls from the autolysis are first treated with the high pH-protease.
- the incubation with the high-pH protease is suitably carried out at a temperature of 50° to 65° C. for approximately 10 to 16 hours.
- the cell walls are then treated with an amylase (or other glucanase) or lipase, or a combination of amylase and lipase.
- the incubation with the amylase and/or a lipase is suitably carried out at a pH of 4 to 7 and a temperature of 50° to 65° C. for approximately 4 to 10 hours.
- the amylase may digest residual alpha-glucans such as glycogen that may still reside with the cell wall.
- the lipase may degrade cell wall membranes enriched with lipids and fats.
- the cell wall stream may then be separated by centrifugation to produce a secondary extract enriched with mannan, and a cell wall product enriched in ⁇ -glucans.
- the cell wall product may be dried, e.g., spray dried.
- the secondary mannan extract may be passed through an ultrafilter, such as a 10,000 Da ultrafilter, a 50,000 Da ultrafilter, or a 100,000 Da ultrafilter to enrich the mannan content of the retentate.
- the preparations of the invention may be dried by any suitable process including, but not limited to, freeze-drying, roller drum drying, oven-drying, spray-drying, ring-drying, and combinations thereof and/or dried using film-forming equipment, and either may be used without further processing, or may be milled using any suitable technique.
- the high-pH protease may have an optimum proteolytic activity at a pH above 7.
- Suitable proteases include, but are not limited to, those obtained from Actinidia chinensis, Ananas comosus, Aspergillus spp. (e.g. A. niger, A. niger var. awamori, A. oryzae, A. sojae, A. melleus ), Bacillus spp. (e.g. B. subtilis, B. alcalophilus, B. amyloliquefaciens, B. halodurans, B. lentus, B. licheniformis, B. stearothermophilus, B.
- Actinidia chinensis e.g. A. niger, A. niger var. awamori, A. oryzae, A. sojae, A. melleus
- Bacillus spp. e.g. B. subtilis
- thermoproteolyticus Carica papya, Cryphonectria parasitica, Endothia parasitica, Ficus glabrata, Kluyveromyces lactis, Penicillum citrinum, Rhizomucor miehei, Rhizopus niveus , from calf, goat or ox stomachs or porcine pancreases, and combinations thereof.
- Suitable amylases include those of plant, animal, bacterial or fungal origin, and combinations thereof.
- Amylases include, but are not limited to, glucoamylases or ⁇ -amylases obtained from Bacillus spp., (e.g., B. licheniformis, B. amyloliquefaciens, B. subtilis, B. stearothermophilus ), Aspergillus oryzae, Aspergillus niger, Aspergillus niger var. awamori, Microbacterium imperiale, Thermomonospora viridis , barley malt ( Hordeum spp.), porcine pancreas ( Sus spp.), and combinations thereof.
- Bacillus spp. e.g., B. licheniformis, B. amyloliquefaciens, B. subtilis, B. stearothermophilus
- Aspergillus oryzae Aspergill
- amylases examples include, but are not limited to, commercially available amylases such as Glucoamylase Concentrate, DuramylTM, TermamylTM, FungamylTM and BANTM (available from Novo Nordisk A/S); RapidaseTM and PurastarTM (available from Genencor International Inc.); and ValidaseTM BAA, ValidaseTM HT340L, ValidaseTM FAA, ValidaseTM AGS, ValidaseTM GA, ValidaseTM RGA (available from Valley Research, South Bend, Ind.), and combinations thereof.
- the amylase may be suitably used at a final concentration of at least 0.001%, particularly at least 0.01% and even more particularly at least 0.02%.
- the amylase may be suitably used at a final concentration of less than 0.1%, particularly less than 0.05%, and even more particularly less than 0.1%.
- Lipases useful in the invention include, but are not limited to, lipases from Humicola (synonym Thermomyces ), e.g. from H. lanuginosa ( T. lanuginosus ), H. insolens , a Pseudomonas lipase, e.g. from P. alcaligenes or P. pseudoalcaligenes, P. cepacia, P. stutzeri, P. fluorescens, Pseudomonas sp. strain SD 705, P. wisconsinensis , a Bacillus lipase, e.g. from B. subtilis, B. stearothermophilus or B.
- lipase enzymes include, but are not limited to, LipolaseTM and Lipolase UltraTM (Novo Nordisk A/S), and Fungal Lipase 8000 and Pancreatic Lipase 250 (available from Valley Research, South Bend, Ind.).
- the product resulting from autolysis of the yeast cells suitably also comprises, at least 20%, particularly at least 23% and more particularly at least 25% protein of the total product on a dry solids basis.
- the product also suitably comprises less than 45%, particularly less than 40% and more particularly less than 35% protein of the total product on a dry solids basis.
- the product resulting from autolysis of the yeast cells suitably comprises at least 20%, particularly at least 23% and more particularly at least 25% total glucans of the total product on a dry solids basis.
- the product also suitably comprises less than 45%, particularly less than 40% and more particularly less than 35% total glucans of the total product on a dry solids basis.
- the product resulting from autolysis of the yeast cells suitably comprises, at least 5%, particularly at least 7% and more particularly at least 10% alpha-glucans of the total product on a dry solids basis.
- the product also suitably comprises less than 20%, particularly less than 18% and more particularly less than 15% alpha-glucans of the total product on a dry solids basis.
- the product resulting from autolysis of the yeast cells suitably comprises, at least 7%, particularly at least 10% and more particularly at least 12% beta-glucans of the total product on a dry solids basis.
- the product also suitably comprises less than 22%, particularly less than 20% and more particularly less than 18% beta-glucans of the total product on a dry solids basis.
- the enriched ⁇ -(1,3/1,6) glucan product cell wall product is characterized, for example, as at least 50%, at least 55%, at least 60% or at least 65% ⁇ -(1,3/1,6) glucan with a protein content of less than 20%, less than 15%, or less than 10%.
- the enriched mannan product (secondary mannan extract) may be characterized as containing at least 50%, particularly at least 55% and even more particularly at least 57% mannan.
- the enriched mannan product may also be characterized as containing less than 70%, particularly less than 68%, and even more particularly less than 65% mannan.
- the ultrafiltration step may be carried out by forcing an extract produced from the processes described herein, such as a secondary mannan extract, through an ultrafilter under pressure.
- the ultrafilter comprises one or more semi-permeable membranes.
- the semi-permeable membrane or ultrafilter may have a molecular weight cut-off of, for example, at least 8,000 Da, particularly at least 10,000 Da, more particularly at least 25,000 Da, even more particularly at least 50,000 Da, still more particularly at least 100,000 Da, and yet still more particularly at least 150,000 Da.
- the ultrafilter may have a molecular weight cut of any value between those recited herein including, but not limited to, a molecular weight cut off of at least 15,000 Da, 20,000 Da, 30,000 Da, 40,000 Da, 60,000 Da, 70,000 Da, 80,000 Da, 90,000 Da, 110,000 Da, 120,000 Da, 130,000 Da and 140,000 Da.
- Suitable ultrafilter membranes include, but are not limited to, hollow fiber membranes available from A/G Technology Corp, Needham, Mass.
- a 50,000 Da cut off is used with a secondary mannan extract, typically at least 80% (w/w), particularly at least 85% (w/w), and more particularly at least 90% (w/w)of the total mannans in the retentate may have a molecular weight above 50,000 Da.
- a 100,000 Da cut off is used with a secondary mannan extract, typically at least 80% (w/w), particularly at least 85% (w/w), and more particularly at least 90% (w/w) of the total mannans in the retentate may have a molecular weight above 100,000 Da.
- a 150,000 Da cut off is used with a secondary mannan extract, typically at least 80% (w/w), particularly at least 85% (w/w), and more particularly at least 90% (w/w)of the total mannans in the retentate may have a molecular weight above 150,000 Da.
- the ultrafiltration step may optionally include passing the mannan extract through two or more ultrafilters of different molecular weight cut offs.
- the final retentate comprises an enriched mannan product wherein a majority of mannans have a molecular weight falling between the molecular weight cut-offs of the ultrafilters.
- at least 80% (w/w), particularly at least 85% (w/w), and more particularly at least 90% (w/w) of the total mannans of the final retentate may suitably have a molecular weight between the molecular weight cut-offs of the ultrafilters.
- the secondary mannan extract which results from separation from the glucan enriched product following enzymatic treatment of autolyzed cell walls is characterized, for example, from 15% to 50% mannan, 20% to 30% protein, and 20% to 25% other components.
- the retentant may comprise at least 50%, particularly at least 52%, more particularly at least 55% and even more particularly at least 60% mannan.
- the retentate may comprise less than 70%, particularly less than 65%, and more particularly less than 62% mannan.
- the retentate may further comprise at least 10%, particularly at least 12%, more particularly at least 15% and even more particularly at least 17% protein.
- the retentate may further comprise less than 33%, particularly less than 30%, and more particularly less than 22% protein.
- the preparations in accordance with the present invention are contemplated to be of value in, e.g., food supplements, pharmaceuticals (e.g., improving immune response), cosmetics, animal feeds, and neutraceuticals.
- an animal feed may suitably contain 1 to lOg of preparation/kg feed.
- the preparation may be comprise at least 0.01%, particularly at least 0.02%, more particularly at least 0.05%, and even more particularly at least 0.1% and less than 5%, particularly less than 2%, more particularly less than 0.5%, and even more particularly less than 0.3% of the total weight of the feed, on a weight/weight basis.
- Suitable animal feeds include, but are not limited to, cattle, horse, swine, poultry, fish (e.g., crustacean, shellfish), bird and pet (e.g., cat, dog) feeds.
- a liquid composition may contain 0.1%-1% by weight of the preparation in accordance with the present invention.
- Preparations according to the invention may also be used in a plant protection composition together with an agriculturally acceptable carrier, and optionally an agriculturally acceptable nutrient, herbicide or pesticide.
- the enriched beta-glucan fractions made according to the present invention may suitably be used as immune stimulators in animal and human foods, pharmaceuticals or emollients, agents to reduce cholesterol, and thickening agents in foods and beverages.
- the beta glucan may be suitably present at a concentration (w/w) of at least 0.05%, particularly at least 0.1% and more particularly at least 0.5%, and less than 10%, particularly less than 5% and more particularly less than 2%.
- the beta-glucan fractions made according to the present invention may be used to treat eczema, for example, by incorporation into a cream, lotion or emollient.
- mannan-enriched products made according to the present invention.
- mannan products may be used in the animal feed industry, having advantageously the ability to bind mycotoxins and also pathogenic bacteria, preventing bacteria from colonizing the intestinal tract.
- the invention provides, among other things, enriched preparations of ⁇ -glucans and mannans, utilizing processes of relatively mild process conditions.
- the insoluble cell wall fraction was washed three times with a volume of water equal to the volume of extract removed.
- the washed cell wall fraction was condensed to 15.4% solids, the pH was adjusted to 7.0 with hydrochloric acid and the fraction was spray dried.
- a portion of the extract from the Protex 6L treatment (corresponding to the 2° extract shown in FIG. 1 ) was condensed to 28.3% solids, the pH was adjusted to 7.0 and the extract was spray dried.
- the remainder of the 2° extract was ultrafiltered using a UFP-10-C-6A 10,000 NMWC hollow fiber membrane (available from A/G Technology Corp, Needham, Mass.).
- the high molecular weight enriched mannan retentate was adjusted to pH 7.0 and spray dried.
- the 3° extract (filtrate) was adjusted to pH 7.0, condensed and spray dried.
- composition of the products resulting from this process were analyzed using the following techniques: protein was determined using a LECO protein determinator (LECO Corp., St. Joseph, Mich.); total glucans, alpha-glucans and beta-glucans were measured using Megazyme International Mushroom and Yeast Beta-glucan kit (available from Megazyme International, Wicklow, Ireland); mannans were determined by acid hydrolysis of carbohydrates and linked spectrophotometric assay for free mannose, using hexokinase, glucose-6-phosphate dehydrogenase, phosphoglucose isomerase and phosphomannose isomerase; fat was determined using the methanol-chloroform extraction method of Blich, E. G. and Dyer, W. J. Can. J. Biochem. Physiol. (1959) 37, 911; free glucose was measured using Yellow Springs Instruments Biochemistry Analyzer (available from YSI Incorporated, Yellow Springs, Ohio). The results of these analyses are shown in Table 1.
- the heated material was separated with a Westfalia bowl separator (available from Westfalia Separator, Inc., Northvale, N.J.). Most of the extract (shown as the 2° extract in FIG. 2 ) was condensed and spray dried. A portion of the 2° extract was ultrafiltered using a UFP-10-C-6A 10,000 NMWC hollow fiber membrane (available from A/G Technology Corp, Needham, Mass.). The retentate and the filtrate were condensed and spray dried. The spray dried products were analyzed according to the techniques described in Example 1. The results are presented in Table 2. The cell wall fraction was water washed by centrifugation, condensed and spray dried.
- the data of table 3 indicate that when glucoamylase is added before the Protex 6L, as in Vessel 1, then the cell walls are not sufficiently altered to permit the glucoamylase to access and digest the large molecular weight ⁇ -glucan (glycogen) that is trapped inside the cell walls following the autolysis of brewer's yeast.
- adding protease prior to the glucoamylase permitted the glucoamylase to access and digest the ⁇ -glucan, and to release substantially more glucose. This is the case, even though the glucoamylase in vessel 1 had a longer time (14 hours) to work at pH 5.0 than the glucoamylase of Vessel 2 (4 hours). Therefore, for optimal removal of glycogen/ ⁇ -glucan from brewer's yeast cell walls, the alkaline protease Protex 6L should be added before the glucoamylase.
- the cell walls resulting from the autolysis of baker's yeast contain lower levels of glycogen than do the cell walls from brewer's yeast, because primarily, aerobic grown baker's yeast tend to accumulate less beta-glucan than anaerobically grown brewer's yeast. More glucose was released from brewer's yeast cell walls following incubation with glucoamylase that from baker's yeast cell walls. The process of FIG. 2 is therefore extremely effective for processing beta-glucan from brewer's yeast cell walls.
- Pigs fed the treatment diet were significantly heavier on day 14 and there was a tendency for the pigs to show increased in weight for the 28 days.
- Table 6 indicates that the 3° extract of the process of FIG. 2 , made according to Example 2, enhanced the palatability of a dry dog food at least as much as, if not more than, the standard palatant.
- a highly purified yeast cell wall product of Saccharomyces cerevisiae is produced according to the process described in Example 2. It has a high concentration of ( ⁇ -1,3/1,6) glucan.
- the product is G.R.A.S. (Generally Recognized as Safe) by the FDA.
- the product can be used to supplement in a wide variety of foods with a high quality natural source of ( ⁇ -1,3/1,6) glucan.
- This biologically active material has been shown to stimulate the immune system of a wide range of animals.
- the composition and characteristics of the product are shown in Table 7.
- Brewer's yeast cell wall cream is heated to 131° F. (55° C.).
- the pH is raised to 9.5 with 50% sodium hydroxide (about 5 ml per Kg of cell wall cream).
- Protex 6L (Genencore) is added to 0.1% (vol: total weight of cell wall cream).
- the mixture is held at 131° F. for 14 hours.
- the pH is lowered to 5.0 with 28% HCI (muriatic acid) and 0.0175% (weight: total weight) Glucoamylase Concentrate (Valley Research) is added.
- the mixture is held at 55° C. for 4 hours, before heat inactivating the enzymes by heating to 185-195° F.
- the fractions are separated. Prior to spray drying the beta-glucan enriched insoluble fraction, the pH is adjusted to 6.5. The beta-glucan enriched insoluble fraction is spray dried.
- Standard chicken feed (without antibiotics) either containing 1 g/Kg of beta-glucan enriched product of Example 2, or containing no beta-glucan (control), is fed daily to broiler chickens from age day 1. After 7 days both the control and the beta-glucan fed chicks are given a respiratory challenge with a strain of E. coli pathogenic for chickens. The chicks are continued on their respective diets, and mortality is recorded for one month.
- the mannan binds to the Salmonella and prevents it from binding to the intestinal tract of the chickens on the mannan feed. This is expected to result in a significant reduction in morbidity and mortality for the mannan fed chickens.
- One group of tiger shrimp ( Penaeus monodon ) are immersed in a solution that does not contain enriched beta-glucan (control group). This group is fed a commercial pellet not containing enriched beta-glucan during the course of the study.
- a second group of tiger shrimp are immersed in a solution containing 0.1% of the enriched beta-glucan from Example 1, and then fed a commercial pellet containing 0.1% of the enriched beta-glucan from Example 1.
- a third group of tiger shrimp are immersed in a solution containing 0.1% of the enriched beta-glucan from Example 2, and then fed a commercial pellet containing 0.1% of the enriched beta-glucan from Example 2. The mortality of each group is monitored over several months.
- yeast beta-1,3-1,6-glucans from Examples 1 and 2 are each expected to stimulate the immune response of shrimp when the shrimp are immersed in solutions containing beta-glucan, and when the shrimp are subsequently fed a feed containing beta-glucan, compared with the control group.
- the groups of tiger shrimp immersed in and fed the yeast beta-glucan diets are expected to grow faster and are expected to have reduced mortality compared with the control group, due to the stimulation of their innate immune systems.
- a select group of children suffering from eczema that is not responsive to current accepted skin lotion treatments is treated with a lotion containing a 1% suspension of the enriched ⁇ -glucan product of Example 2.
- the lotion is applied twice daily.
- the skin is evaluated weekly by a dermatologist for improvement of lesions and pain.
- the ⁇ -glucan lotion is expected to decrease the lesions associated pain and quickens the healing of the lesions.
- Yeast beta-glucan extract from Example 2 is added to ice-cream at 1% (w/w) as a partial replacement for fat.
- the beta-glucan adds a firmness and body to the ice-cream without affecting the texture.
- the beta-glucan supplemented ice-cream contains fewer calories than ice-cream not containing beta-glucan.
- the beta glucans are expected to stimulate the innate immune system of the intestinal tract and benefit the immune status of the consumer.
- the yeast beta-glucan extract from Example 2 is added at 0.5% (w/w) and 1% (w/w) to cookies, snack bars and bakery items.
- the beta-glucan supplemented cookies, snack bars and bakery items contain fewer calories than cookies, snack bars and bakery items not containing beta-glucan.
- the beta glucans are expected to stimulate the innate immune system of the intestinal tract and benefit the immune status of the consumer.
Abstract
Description
TABLE 1 |
Characterization of Products |
Total | Alpha | Beta- | Free | |||||
glucans | Glucans | glucans | Glucose | Mannans | Fat % | |||
% (dry | % (dry | % (dry | % (dry | % (dry | (dry | |||
solids | solids | solids | solids | solids | solids | |||
Product | Protein % | Ash % | basis) | basis) | basis) | basis) | basis) | basis) |
Starting | 31.4 | 3.5 | 28.9 | 12.4 | 16.5 | 1.2 | 13.6 | ND |
brewer's | ||||||||
yeast cell | ||||||||
wall | ||||||||
Alkaline | 8.6 | 2.5 | 54.6 | 29.2 | 25.4 | 0.0 | 5.7 | 14.2 |
Protease Cell | ||||||||
Wall | ||||||||
2° Extract | 39.9 | 10.9 | ND | ND | ND | 1.0 | 22.6 | ND |
Ultrafilter | 29.6 | 5.9 | ND | ND | ND | 0.0 | 62.7 | ND |
retentate | ||||||||
3° Extract | 52.3 | 13.6 | ND | ND | ND | 1.8 | 8.6 | ND |
(filtrate from | ||||||||
ultrafiltration) | ||||||||
ND means not determined. |
TABLE 2 |
Characterization of Products made according to Process Depicted in FIG. 2 |
Total | Alpha | Beta | Free | |||||
Glucan | Glucan | Glucan | Glucose | Mannan | Fat % | |||
% (dry | % (dry | % (dry | % (dry | % (dry | (dry | |||
solids | solids | solids | solids | solids | solids | |||
Product | Protein % | Ash % | basis) | basis) | basis) | basis) | basis) | basis) |
Cell walls | 12.4 | 4.3 | 53.0 | 2.4 | 50.6 | 5.0 | 4.8 | 15.2 |
from enzyme | ||||||||
treatments | ||||||||
2° Extract | 26.4 | 11.3 | ND | ND | ND | 29.4 | 17.4 | ND |
Ultrafilter | 20.7 | 5.0 | 9.5 | 0.0 | 0.0 | 9.3 | 54.2 | ND |
retentate | ||||||||
3° extract | 30.1 | 12.6 | 31.6 | 0.0 | 0.0 | 33.9 | 3.5 | ND |
(filtrate from | ||||||||
ultrafiltration) | ||||||||
ND means not determined. |
TABLE 3 |
Release of glucose from α-glucans of |
brewer's yeast cell walls (g/L free glucose) |
Vessel 1 | Vessel 2 | ||
Glucoamylase | Protex 6L then | ||
then Protex 6L | Glucoamylase | ||
Zero hours at 55° C. | 0.48 | 0.48 | ||
14 hours at 55° C. | 4.52 | 0.35 | ||
18 hours at 55° C. | 3.63 | 46.2 | ||
TABLE 4 |
Comparison of Glucose Released From Baker's and Brewer's |
Yeast Cell Walls Using the Process Shown in FIG. 2. |
% Free Glucose | Baker's Yeast | Brewer's Yeast | ||
(dry solids basis) | Cell Walls | Cell Walls | ||
At Start | 0.0 | 0.41 | ||
After Protex 6L | 0.0 | 0.30 | ||
After | 1.2 | 39.2 | ||
Glucoamylase | ||||
TABLE 5 |
Body Weight, lb. (mean) |
Days |
7 (end of | 14 (end of | 28 (end of | ||
Treatment | 0 | Phase 1) | Phase 2) | Phase 3) |
Control | 12.22 | 14.02 | 18.35a | 32.63 |
50:50 Crude | 12.22 | 14.03 | 19.69b | 33.88 |
cell wall:extract | ||||
a,bMeans significantly differ, P < 0.10. |
TABLE 6 | ||
1.0% 3° | 1.0% Standard | |
Extract | Palatant |
DOG # | WT. Kg. | DAY 1 | DAY 2 | DAY 1 | DAY 2 |
1 | 22.7 | 366 | 178 | 125 | 325 |
2 | 32.0 | 385 | 591 | 180 | 40 |
3 | 27.2 | 879 | 1000 | 65 | 119 |
4 | 22.4 | 2 | 670 | 571 | 0 |
5 | 23.3 | 34 | 274 | 656 | 438 |
6 | 21.9 | 412 | 576 | 4 | 0 |
7 | 29.1 | 456 | 219 | 111 | 374 |
8 | 25.3 | 561 | 455 | 68 | 148 |
9 | 24.6 | 83 | 400 | 622 | 431 |
10 | 25.4 | 382 | 507 | 126 | 191 |
11 | 22.9 | 683 | 696 | 187 | 288 |
12 | 28.1 | 278 | 2 | 221 | 583 |
13 | 25.0 | 0 | 672 | 300 | 0 |
14 | 26.6 | 53 | 0 | 341 | 425 |
15 | 36.8 | 89 | 444 | 642 | 406 |
16 | 22.5 | 560 | 536 | 149 | 69 |
17 | 28.9 | 286 | 394 | 98 | 0 |
18 | 22.0 | 220 | 494 | 309 | 184 |
19 | 24.8 | 320 | 4 | 1 | 391 |
20 | 16.8 | 220 | 470 | 265 | 50 |
TOTAL | 508.3 |
TOTAL per day | 6269 | 8582 | 5041 | 4462 |
GRAND TOTAL | 14851 = | 9503 = |
14.6 g/Kg/day | 9.3 g/Kg/day | |
TABLE 7 | ||
Characteristics | Value/Average | Method |
Chemical | ||
β-1,3/1,6 glucan | 50.0% Minimum | Megazyme Method |
Protein (N × 6.25) | 15.0% Maximum | Perkin Elmer |
Moisture | 6.0% Maximum | Standard method |
pH (10% Solution) | 5 ± 0.3 | pH Meter |
Microbiological | ||
Total Bacterial Count | 15,000/g Max. | BAM |
Yeast and Mold | 100/g Max. | BAM |
Coliform Organisms | 10/g Max. | BAM |
E. Coli | Negative | BAM |
Salmonella | Negative | BAM |
-
- A. 0.0175% Glucoamylase Concentrate (available from Valley Research)
- B. 0.1% Lipase CR (a triacylglycerol lipase available from Valley Research)
- C. 0.0175% Glucoamylase Concentrate+0.1% Lipase CR.
TABLE 8 | ||||
Enzyme treatment | ||||
for 4 hours after | Beta-glucan % (dry | |||
Protex 6L | Protein % | solids basis) | ||
A: Glucoamylase | 34.2 | 27.3 | ||
Concentrate | ||||
B: Lipase CR | 34.3 | 27.1 | ||
C: Glucoamylase | 30.5 | 30.8 | ||
Concentrate plus | ||||
Lipase CR | ||||
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/693,164 US8753668B2 (en) | 2005-05-05 | 2010-01-25 | Production of beta-glucans and mannans |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67797305P | 2005-05-05 | 2005-05-05 | |
US11/418,922 US20060263415A1 (en) | 2005-05-05 | 2006-05-05 | Production of beta-glucans and mannans |
US12/693,164 US8753668B2 (en) | 2005-05-05 | 2010-01-25 | Production of beta-glucans and mannans |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/418,922 Continuation US20060263415A1 (en) | 2005-05-05 | 2006-05-05 | Production of beta-glucans and mannans |
Publications (2)
Publication Number | Publication Date |
---|---|
US20100190872A1 US20100190872A1 (en) | 2010-07-29 |
US8753668B2 true US8753668B2 (en) | 2014-06-17 |
Family
ID=36920048
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/418,922 Abandoned US20060263415A1 (en) | 2005-05-05 | 2006-05-05 | Production of beta-glucans and mannans |
US12/693,164 Active 2028-12-27 US8753668B2 (en) | 2005-05-05 | 2010-01-25 | Production of beta-glucans and mannans |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/418,922 Abandoned US20060263415A1 (en) | 2005-05-05 | 2006-05-05 | Production of beta-glucans and mannans |
Country Status (7)
Country | Link |
---|---|
US (2) | US20060263415A1 (en) |
EP (1) | EP1877447B1 (en) |
JP (1) | JP5296531B2 (en) |
CN (1) | CN101184780B (en) |
CA (2) | CA2607004C (en) |
MX (1) | MX2007013725A (en) |
WO (1) | WO2006121803A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170196231A1 (en) * | 2014-06-26 | 2017-07-13 | E I Du Pont De Nemours And Company | Production of poly alpha-1,3-glucan formate food casings |
US10059778B2 (en) | 2014-01-06 | 2018-08-28 | E I Du Pont De Nemours And Company | Production of poly alpha-1,3-glucan films |
US10106626B2 (en) | 2014-01-17 | 2018-10-23 | Ei Du Pont De Nemours And Company | Production of poly alpha-1,3-glucan formate films |
US10842809B2 (en) | 2016-12-16 | 2020-11-24 | Hills Pet Nutrition, Inc. | Pet food compositions |
US10973245B2 (en) * | 2016-06-24 | 2021-04-13 | Yessinergy Holding S/A | Immunomodulatory and growth promoting and controlling composition of intestinal microbiota undesirable bacteria and its use |
WO2021195605A1 (en) * | 2019-03-27 | 2021-09-30 | West Virginia University | Vaccine formulation to protect against pertussis |
WO2021209959A2 (en) | 2020-04-17 | 2021-10-21 | Compañia Nacional De Levaduras, Levapan S.A. | Method for obtaining βeta-glucan from baker's yeast |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050026866A1 (en) * | 2002-08-02 | 2005-02-03 | Pawelek John M. | Agents and methods for treatment of disease by oligosaccharide targeting agents |
FI20070471A0 (en) | 2007-06-13 | 2007-06-13 | Glykos Finland Oy | Ravinnelisäkompositiota |
US20080160043A1 (en) * | 2007-07-16 | 2008-07-03 | Kim Moo-Sung | Preparation method of beta-glucan from schizophyllum commune and composition for external application comprising the same |
CN101361524B (en) * | 2007-08-10 | 2011-12-07 | 安琪酵母股份有限公司 | Biotoxin adsorbent and production method thereof |
MX2010008038A (en) * | 2008-01-28 | 2010-08-30 | Archer Daniels Midland Co | Compositions for feeding animals. |
CN101570769B (en) * | 2008-04-29 | 2013-06-19 | 安琪酵母股份有限公司 | Yeast glucan and mannan and production method thereof |
JP2010077039A (en) * | 2008-09-24 | 2010-04-08 | Fujifilm Corp | Immunostimulator or antiallergic agent |
FI20080665A0 (en) * | 2008-12-18 | 2008-12-18 | Glykos Finland Oy | Natural saccharide compositions |
US20110091938A1 (en) * | 2009-10-20 | 2011-04-21 | Grain Processing Corporation | Starch Hydrolysis |
CN102051400B (en) | 2009-11-06 | 2013-05-15 | 安琪酵母股份有限公司 | Preparation method of yeast mannose glycoprotein product |
US8575320B2 (en) | 2010-03-18 | 2013-11-05 | Alltech, Inc. | Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins |
US8263752B2 (en) | 2010-03-18 | 2012-09-11 | Alltech, Inc. | Methods for separating soluble selenoglycoproteins |
EP2787070A3 (en) * | 2011-07-21 | 2015-03-11 | AB Enzymes GmbH | Process of lysing yeast cell walls |
US11096408B2 (en) * | 2011-08-26 | 2021-08-24 | Mitsubishi Corporation Life Sciences Limited | Yeast extract having taste-enhancing effect |
FR2981075A1 (en) * | 2011-10-11 | 2013-04-12 | Kitozyme | PROCESS FOR THE PREPARATION OF GLUCANS FROM ASPERGILLUS NIGER |
CN102492052A (en) * | 2011-12-19 | 2012-06-13 | 成都宏安生物科技有限公司 | Method for extracting mannan from waste residue of beer yeast |
CN103243028B (en) * | 2012-02-02 | 2015-11-25 | 安琪酵母股份有限公司 | Yeast cells wall and method for making, fodder additives and method for making thereof and feed |
MX2014010048A (en) * | 2012-02-22 | 2015-03-19 | Algal Scient Corp | Animal feed compositions and methods of using the same. |
JP6105553B2 (en) * | 2012-03-12 | 2017-03-29 | 日之出産業株式会社 | Novel microorganisms of the genus Bacillus and their use |
BR112014023611B1 (en) | 2012-03-23 | 2021-08-31 | Pharma73, S.A. | BIOCOMPOSITE POWDER, METHOD OF PREPARATION OF A BIOCOMPOSITE POWDER AND USE OF SUCH BIOCOMPOSITE POWDER |
CN102669431A (en) * | 2012-05-25 | 2012-09-19 | 兰州鑫祥生物工程有限公司 | Application of yeast beta-glucan as lamb early stage weaning feed additive |
MD4216C1 (en) * | 2012-08-15 | 2013-11-30 | Институт Микробиологии И Биотехнологии Академии Наук Молдовы | Strain of Saccharomyces cerevisiae yeast - producer of mannans |
CN102911287B (en) * | 2012-11-21 | 2014-07-23 | 福建科宏生物工程有限公司 | Method for preparing bamboo leaf polysaccharides from bamboo pulp |
EP2958437B1 (en) * | 2013-02-21 | 2020-02-05 | Direvo Industrial Biotechnology GmbH | Prebiotic animal feed product |
MD4329C1 (en) * | 2013-10-30 | 2015-09-30 | Институт Микробиологии И Биотехнологии Академии Наук Молдовы | Process for cultivation of yeast strain Saccharomyces cerevisiae CNMN-Y-20 |
WO2015160818A1 (en) * | 2014-04-14 | 2015-10-22 | Biothera, Inc. | Yeast cell wall enriched in mannan oligosaccharide protein |
JP6654561B2 (en) * | 2014-05-08 | 2020-02-26 | 三菱商事ライフサイエンス株式会社 | Yeast extract that suppresses flocculation and precipitation generated in foods and beverages |
MX2016015197A (en) | 2014-05-21 | 2017-06-29 | Pharma73 S A | Chitin-glucan complex, its preparation, and uses. |
WO2016010064A1 (en) * | 2014-07-16 | 2016-01-21 | 興人ライフサイエンス株式会社 | Cloudiness-inhibiting agent for tea beverage |
JP6096158B2 (en) * | 2014-09-17 | 2017-03-15 | 富士フイルム株式会社 | Immunostimulatory or antiallergic agent |
CN104403023B (en) * | 2014-11-13 | 2017-02-08 | 成都天屹生物科技有限公司 | Method for extracting alkali-insoluble glucan from beer waste yeast residue |
TWI674070B (en) * | 2014-11-19 | 2019-10-11 | 日商泰寶美客股份有限公司 | Method of improving flavor of yeast cells and food quality improvement agent |
CN105017441B (en) * | 2015-08-31 | 2018-01-16 | 桂林茗兴生物科技有限公司 | The extracting method of GL-B |
CA2997401C (en) | 2015-09-21 | 2023-06-13 | Dsm Ip Assets B.V. | Yeast cell wall derived flavour |
EP3180990A1 (en) | 2015-12-16 | 2017-06-21 | Neste Oyj | Method for preparing a composition having antimicrobial activity |
JP2019510037A (en) | 2016-03-31 | 2019-04-11 | ゴジョ・インダストリーズ・インコーポレイテッド | Antibacterial peptide stimulant cleaning composition |
JP2019510036A (en) | 2016-03-31 | 2019-04-11 | ゴジョ・インダストリーズ・インコーポレイテッド | A detergent composition comprising probiotic / prebiotic active ingredients |
TWI723161B (en) * | 2016-05-16 | 2021-04-01 | 日商興人生命科學股份有限公司 | Salt enhancement method |
IT201600069379A1 (en) * | 2016-07-04 | 2018-01-04 | Prosol S P A | Composition consisting substantially of cell walls of yeast and process for its preparation |
CA3043748A1 (en) | 2016-11-23 | 2018-05-31 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
CN109303195B (en) * | 2017-07-28 | 2021-09-07 | 安琪酵母股份有限公司 | Yeast cell wall capable of replacing antibiotics and preparation method and application thereof |
WO2020004568A1 (en) * | 2018-06-28 | 2020-01-02 | アサヒグループホールディングス株式会社 | Equol production promotor and food or beverage composition comprising same for promotion of equol production |
JP6530846B1 (en) * | 2018-10-09 | 2019-06-12 | アサヒグループホールディングス株式会社 | Immunostimulatory agent and method for preventing infection |
US20210369766A1 (en) * | 2018-10-17 | 2021-12-02 | Institute For Basic Science | Structural and functional characteristics of yeast-derived polysaccharide inducing treg cell |
CN111172219A (en) * | 2020-02-17 | 2020-05-19 | 武汉轻工大学 | Mannan, preparation method and application thereof, and hot dry noodles |
US11140912B1 (en) | 2020-12-22 | 2021-10-12 | Agvault, Llc | Process for manufacturing yeast strains having increased mannan oligosaccharides and improved amino acid profiles |
WO2022155314A1 (en) * | 2021-01-13 | 2022-07-21 | AMI Newco LLC | Mushroom blend for increasing butyrate production in the gut biome |
EP4119654A1 (en) * | 2021-07-12 | 2023-01-18 | Yeastup AG | Method for the isolation of proteins and saccharides from yeast |
CN115501246B (en) * | 2022-10-31 | 2023-08-08 | 湖南天根乐微君科技有限公司 | Composition capable of effectively repairing, desalting and removing scars and preparation method and application thereof |
Citations (386)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1003976A (en) | 1961-02-23 | 1965-09-08 | Kinki Yakult Seizo Kabushiki K | Method of decomposing the cell walls of yeasts with ª‰-glucanase produced by microorganisms |
BE662884A (en) | 1964-04-23 | 1965-10-22 | ||
US3495990A (en) | 1967-03-02 | 1970-02-17 | Pillsbury Co | Aerated food products |
US3754925A (en) | 1970-03-24 | 1973-08-28 | Takeda Chemical Industries Ltd | New thermo gelable polysaccharide containing foodstuffs |
US3867554A (en) | 1972-11-29 | 1975-02-18 | Robert William Sucher | Yeast glycan and process of making same |
US3880742A (en) | 1972-02-22 | 1975-04-29 | Glaxo Lab Ltd | {62 -1,4,/{62 1,3 Glucanase |
US3934039A (en) | 1972-11-30 | 1976-01-20 | Societa' Italiana Resine S.P.A. | Process for the production of microorganism lysates |
US3943247A (en) | 1972-05-22 | 1976-03-09 | Kaken Kagaku Kabushiki Kaisha | Treatment of bacterial infections with glucan compositions |
US3961080A (en) | 1972-10-17 | 1976-06-01 | Kikkoman Shoyu Co., Ltd. | Process for autolysis of yeast |
US3973008A (en) | 1970-12-30 | 1976-08-03 | Kabushiki Kaisha Shimizu Manzo Shoten | Konjac mannan |
US3975553A (en) | 1965-03-08 | 1976-08-17 | Henri Griffon | Deproteination of yeast cells |
US3989847A (en) | 1975-05-20 | 1976-11-02 | Shinji Kurihara | Process for preparation of seasonings derived from animal meat |
US4016295A (en) | 1973-10-18 | 1977-04-05 | Pedigree Petfoods Limited | Proteinaceous food product |
US4036993A (en) | 1975-04-25 | 1977-07-19 | Tensei Suisan Company, Limited | Process for preparation of fish meat extracts |
US4041152A (en) | 1973-07-27 | 1977-08-09 | Charles Chany | Pharmaceutical formulation of interferon insolubilized by fixation on a support |
US4041181A (en) | 1973-10-18 | 1977-08-09 | Pedigree Petfoods Limited | Pet food and method of making same |
US4066793A (en) | 1974-03-18 | 1978-01-03 | Ajinomoto Co., Inc. | Seasoning composition and preparation thereof |
US4072567A (en) | 1975-12-11 | 1978-02-07 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Compound water-insoluble glucan and process for the production thereof |
US4075405A (en) | 1974-11-26 | 1978-02-21 | Takeda Chemical Industries, Ltd. | β-1,3-Glucan derivatives |
GB1502902A (en) | 1974-11-05 | 1978-03-08 | Bayer Ag | Extraction products from material containing or derived from yeast cell walls |
US4088539A (en) | 1976-05-07 | 1978-05-09 | A. Nattermann & Cie Gmbh | Process of manufacturing enzyme preparation rich in lipase |
US4122196A (en) | 1974-11-18 | 1978-10-24 | Anheuser-Busch, Incorporated | Process for the manufacture of yeast glycan |
US4138479A (en) | 1975-11-07 | 1979-02-06 | Bayer Aktiengesellschaft | Process for the preparation of immunopotentiating agents from components of yeast cell wall material |
US4158607A (en) | 1976-10-19 | 1979-06-19 | Instytut Przemyslu Mleczarskiego | Enzymatic preparation for ripening of milk protein products |
CA1074453A (en) | 1976-11-29 | 1980-03-25 | Arun K. Pandeya | Parallel data processor apparatus |
US4207344A (en) | 1975-06-14 | 1980-06-10 | Cerrillo Vincente P | Processes for protecting proteic foodstuffs against spoilage |
US4211645A (en) | 1976-07-16 | 1980-07-08 | Abitibi Paper Company Ltd. | Foam flotation activated sludge process |
US4216293A (en) | 1973-10-05 | 1980-08-05 | Laboraton Derivati Organici, S.p.A. | Extracting protease-inhibitor from animal tissue containing same |
US4218481A (en) | 1978-10-06 | 1980-08-19 | Standard Oil Company (Indiana) | Yeast autolysis process |
US4244973A (en) | 1978-06-26 | 1981-01-13 | Lever Brothers Company | Process for producing a detoxified rapeseed protein concentrate |
US4247541A (en) | 1978-05-12 | 1981-01-27 | Kirin Brewery Company Limited | Ks-2-b |
US4247574A (en) | 1979-06-22 | 1981-01-27 | The Calpis Food Industry Co., Ltd. | Method of producing textured protein and textured protein produced thereby |
US4279653A (en) | 1975-12-05 | 1981-07-21 | Dai Nippon Toryo Co., Ltd. | Ink composition for ink jet recording |
US4285976A (en) | 1979-11-23 | 1981-08-25 | Standard Oil Company (Indiana) | Method for accelerating autolysis of yeast |
US4295889A (en) | 1978-12-01 | 1981-10-20 | Canon Kabushiki Kaisha | Recording liquid composition |
US4299630A (en) | 1977-04-27 | 1981-11-10 | The Mead Corporation | Infrared absorptive jet printing ink |
US4303680A (en) | 1979-01-05 | 1981-12-01 | Ajinomoto Company, Incorporated | Production of yeast extract containing flavoring |
US4310553A (en) | 1980-02-25 | 1982-01-12 | Odintsova Ekaterina N | Process for producing food vitamin concentrate from wine yeast |
US4311714A (en) | 1979-06-12 | 1982-01-19 | Endowment And Research Foundation At Montana State University | Production of products from waxy barley grain |
US4311717A (en) | 1980-05-19 | 1982-01-19 | Fmc Corporation | Stabilizing agent for dry mix food products |
US4313934A (en) | 1979-05-08 | 1982-02-02 | Kirin Beer Kabushiki Kaisha | Physiologically active polysaccharides, production and uses thereof |
US4332894A (en) | 1980-08-15 | 1982-06-01 | Purdue Research Foundation | Conversion of guar gum to gel-forming polysaccharides by the action of α-galactosidase |
US4339360A (en) | 1979-03-31 | 1982-07-13 | Agency Of Industrial Science & Technology | Particles of activated oxidized polysaccharide substance coated with inactive protective layer and method for manufacture thereof |
US4340675A (en) | 1979-05-17 | 1982-07-20 | De Forenede Bryggerier A/S | Process for recovering Cu,Zn-superoxide dismutase from yeast |
US4344968A (en) | 1978-12-09 | 1982-08-17 | Nippon Kayaku Kabushiki Kaisha | Pharmaceutical vehicle |
US4361843A (en) | 1981-03-27 | 1982-11-30 | Exxon Research And Engineering Co. | Ink jet compositions and method |
US4368322A (en) | 1978-06-14 | 1983-01-11 | Anic, S.P.A. | Chitosan-glucan complex, method for its production and end uses |
US4381946A (en) | 1980-02-25 | 1983-05-03 | Konishiroku Photo Industry Co., Ltd. | Ink composition for ink-jet recording |
US4383859A (en) | 1981-05-18 | 1983-05-17 | International Business Machines Corporation | Ink jet inks and method of making |
US4388115A (en) | 1980-06-13 | 1983-06-14 | Fuji Photo Film Co., Ltd. | Aqueous ink composition |
US4427710A (en) | 1981-12-23 | 1984-01-24 | Nissin Shokuhin Kabushiki Kaisha | Method of manufacturing an instant bean curd or tofu, and the toju made by such method |
US4454315A (en) | 1976-11-18 | 1984-06-12 | Takeda Chemical Industries, Ltd. | Carboxymethylated derivatives of β-1,3-glucan |
US4477655A (en) | 1982-04-05 | 1984-10-16 | Imperial Chemical Industries Plc | Moulding of poly-hydroxybutyrate containing bacterial cell fragments |
US4484012A (en) | 1984-02-29 | 1984-11-20 | General Foods Corporation | Production of mannitol and higher manno-saccharide alcohols |
FR2470598B1 (en) | 1979-11-29 | 1984-11-30 | Colorcon | |
US4500355A (en) | 1982-10-29 | 1985-02-19 | Ricoh Company, Ltd. | Aqueous ink composition |
US4508570A (en) | 1981-10-21 | 1985-04-02 | Ricoh Company, Ltd. | Aqueous ink for ink-jet printing |
US4508745A (en) | 1982-12-30 | 1985-04-02 | General Foods Corporation | Production of a mannan oligomer hydrolysate |
US4513019A (en) | 1983-07-06 | 1985-04-23 | Seppic | Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions |
US4526794A (en) | 1982-03-08 | 1985-07-02 | General Foods Corporation | Citrus albedo bulking agent and process therefor |
US4544552A (en) | 1982-05-28 | 1985-10-01 | Solco Basel Ag | Process for the preparation of cell and tissue regenerating substances |
US4572832A (en) | 1982-10-07 | 1986-02-25 | Grelan Pharmaceutical Co., Ltd. | Soft buccal |
US4576646A (en) | 1983-07-06 | 1986-03-18 | Seppic | Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions |
US4584197A (en) | 1983-03-04 | 1986-04-22 | Nihon Bussan Kabushiki Kaisha | Process for preparation of fish and shellfish extracts having pharmaceutical functions |
US4587285A (en) | 1982-04-08 | 1986-05-06 | Fritz-Werner Industrie-Ausruestungen Gmbh | Aqueous heat-curable compositions, and their use |
US4588827A (en) | 1984-02-23 | 1986-05-13 | Basf Aktiengesellschaft | Preparation of tetrahydrofuran |
US4620876A (en) | 1982-08-23 | 1986-11-04 | Ricoh Company, Ltd. | Aqueous ink for ink-jet printing |
US4623624A (en) | 1982-12-30 | 1986-11-18 | Basf Aktiengesellschaft | Isolation of pancreatin |
US4652455A (en) | 1984-04-19 | 1987-03-24 | Sugiyo Co., Ltd. | Simulated lobster meat and process for preparing same |
US4659388A (en) | 1984-06-08 | 1987-04-21 | Daicel Chemical Industries, Ltd. | Additive composition for foods or drugs |
US4676976A (en) | 1985-03-08 | 1987-06-30 | Ajinomoto Co., Inc. | Konjak mannan-containing reversible gel |
US4692404A (en) | 1983-11-18 | 1987-09-08 | Fujirebio Kabushiki Kaisha | Method of measuring biological ligand by the use of enzymes |
US4692094A (en) | 1980-11-19 | 1987-09-08 | Messerschmitt-Bolkow-Blohm Gmbh | Rotary positionable installation |
US4707471A (en) | 1983-12-19 | 1987-11-17 | Medicarb Ab | Water-soluble aminated β-1,3-bound D-glucan and composition containing same |
US4731248A (en) | 1986-02-18 | 1988-03-15 | Ralston Purina Company | Production of palatability enhancers from the autolysis of filamentous fungi |
US4737190A (en) | 1984-10-23 | 1988-04-12 | Ricoh Company, Ltd. | Aqueous ink composition for ink-jet recording |
US4739046A (en) | 1985-08-19 | 1988-04-19 | Luzio Nicholas R Di | Soluble phosphorylated glucan |
US4741907A (en) | 1984-12-17 | 1988-05-03 | Asahi Kasei Kogyo Kabushiki Kaisha | Fresh dough and a method for producing the same |
US4749566A (en) | 1984-11-29 | 1988-06-07 | Sanofi | Pharmaceutical composition comprising a combination of at least one immunotoxin and at least one mannose-containing polymer |
US4759942A (en) | 1985-09-19 | 1988-07-26 | General Foods Corporation | Process for producing high fiber expanded cereals |
US4761405A (en) | 1987-03-04 | 1988-08-02 | Nova Pharmaceutical Corporation | Antagonists of specific excitatory amino acid neurotransmitter receptors having increased potency |
US4765992A (en) | 1984-06-01 | 1988-08-23 | Universite De Bordeaux Ii | Stimulation of alcoholic fermentation by adsorption of toxic substances with cell walls |
US4769363A (en) | 1984-03-08 | 1988-09-06 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Beta-glucan |
US4774093A (en) | 1985-06-25 | 1988-09-27 | Fmc Corporation | Polysaccharide compositions, preparation and uses |
US4793860A (en) | 1986-04-02 | 1988-12-27 | Ricoh Company, Ltd. | Aqueous ink composition |
US4795745A (en) | 1984-09-19 | 1989-01-03 | Larm Karl O P | Macrophage-activating composition and a process for its manufacture |
US4795653A (en) | 1986-06-16 | 1989-01-03 | Bommarito Alexander A | Dietary fiber and method of making |
US4798730A (en) | 1987-06-01 | 1989-01-17 | General Foods Corporation | Hydrolysis of a partially extracted roasted and ground coffee |
US4804545A (en) | 1984-08-10 | 1989-02-14 | Barco, Inc. | Production of beta-glucan, bran, protein, oil and maltose syrup from waxy barley |
US4806474A (en) | 1985-06-10 | 1989-02-21 | Miles Inc. | Preparation of mycelial chitosan and glucan fractions from microbial biomass |
US4808419A (en) | 1987-02-02 | 1989-02-28 | Hsu Edward J | Automated method for a semi-solid fermentation used in the production of ancient quality rice vinegar and/or rice wine |
US4810646A (en) | 1984-11-28 | 1989-03-07 | Massachusetts Institute Of Technology | Glucan compositions and process for preparation thereof |
US4810509A (en) | 1986-06-09 | 1989-03-07 | Takeda Chemical Industries, Ltd. | Method for producing yeast extract |
US4818751A (en) | 1985-07-02 | 1989-04-04 | Zeria Shinyaku Kogyo Kabushiki Kaisha | Cosmetics |
US4835265A (en) | 1985-06-21 | 1989-05-30 | Consiglio Nazionale Delle Ricerche | Substituted and crosslinked glucans, process and intermediates for preparing them and use thereof |
US4859488A (en) | 1987-09-15 | 1989-08-22 | Kabushiki Kaisha Yakult Honsha | Liquid food for curing constipation: polydextrose and oligosaccharide |
US4863746A (en) | 1987-03-05 | 1989-09-05 | Asahi Denka Kogyo Kabushiki Kaisha | Proteinous material |
US4871571A (en) | 1987-06-30 | 1989-10-03 | Novo Industri A/S | Dietetic foodstuff containing low calorie bulking agent |
US4876103A (en) | 1987-10-09 | 1989-10-24 | Governor Of Gunma-Ken | Process for making meat products containing a konjac mannan gel |
US4882160A (en) | 1985-12-20 | 1989-11-21 | Warner Lambert Co. | Confectionery delivery system for dictary fiber |
US4891220A (en) | 1988-07-14 | 1990-01-02 | Immudyne, Inc. | Method and composition for treating hyperlipidemia |
US4900722A (en) | 1985-08-19 | 1990-02-13 | Bioglucans, L.P. | Methods and compositions for prophylactic and therapeutic treatment of infections |
US4900571A (en) | 1983-01-28 | 1990-02-13 | Nippon Suisan Kabushiki Kaisha | Process for producing a shark fin analog |
US4942540A (en) | 1987-03-02 | 1990-07-17 | Wang Laboratories, Inc. | Method an apparatus for specification of communication parameters |
US4943444A (en) | 1987-12-22 | 1990-07-24 | Kabushikikaisha Kibun | Jelly resembling the flesh of fruit and process for producing the same |
US4948598A (en) | 1988-01-20 | 1990-08-14 | Biodyn Ag | Process for the production of sparkling wine |
US4950749A (en) | 1989-01-06 | 1990-08-21 | The Standard Oil Company | Recovery of glucan by employing a divalent cation at an alkaline pH |
US4962094A (en) | 1988-10-28 | 1990-10-09 | Alpha Beta Technology, Inc. | Glucan dietary additives |
US4965347A (en) | 1986-03-03 | 1990-10-23 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Beta-D-glucan, and its production and uses |
US4975421A (en) | 1985-08-19 | 1990-12-04 | Bioglucan, Lp. | Soluble phosphorylated glucan: methods and compositions for wound healing |
US4978551A (en) | 1989-08-08 | 1990-12-18 | Sugiyo Co., Ltd. | Simulated fish meat and method of producing same |
US4981700A (en) | 1986-11-14 | 1991-01-01 | Sarishvili Naskid G | Process for producing sparkling wines |
US4986999A (en) | 1987-07-20 | 1991-01-22 | Nihon Bussan Kabushiki Kaisha | Anti-denaturation agent for edible paste product |
US4992540A (en) | 1984-11-28 | 1991-02-12 | Massachusetts Institute Of Technology | Glucan composition and process for preparation thereof |
US4994285A (en) | 1986-10-22 | 1991-02-19 | Asahi Kasei Kogyo Kabushiki Kaisha | Edible body and process for preparation thereof |
US5008125A (en) | 1989-04-17 | 1991-04-16 | Kraft General Foods, Inc. | Soluble coffee with aroma recovered from the thermal hydrolysis of spent grounds |
US5017224A (en) | 1989-05-10 | 1991-05-21 | Kabushiki Kaisha Pilot | Water-resistant ink composition |
US5028703A (en) | 1988-03-11 | 1991-07-02 | Massachusetts Institute Of Technology | Glucan composition and process for preparation thereof |
US5032401A (en) | 1989-06-15 | 1991-07-16 | Alpha Beta Technology | Glucan drug delivery system and adjuvant |
US5037972A (en) | 1984-11-28 | 1991-08-06 | Massachusetts Institute Of Technology | Glucan composition and process for preparation thereof |
EP0273000B1 (en) | 1986-12-16 | 1991-09-04 | Warner-Lambert Company | Xylitol coated comestible and method of preparation |
EP0416343A3 (en) | 1989-09-04 | 1991-09-25 | Consiglio Nazionale Delle Ricerche | Process for preparing a glucane-containing product starting from candida albicans bmm-12 |
US5057503A (en) | 1989-01-23 | 1991-10-15 | The Brigham And Women's Hospital | Derivativized polysaccharides with biologic activity, method of their isolation, and uses therefor |
AU7586091A (en) | 1990-03-27 | 1991-10-21 | Societe D'exploitation De Produits Pour Les Industries Chimiques - Seppic | Film-forming product intended for coating solid forms |
US5082936A (en) | 1984-11-28 | 1992-01-21 | Massachusetts Institute Of Technology | Glucan composition and process for preparation thereof |
US5084386A (en) | 1989-03-31 | 1992-01-28 | Sri International | Production of beta-1,3-glucan in euglena |
US5116631A (en) | 1988-12-26 | 1992-05-26 | Ajinomoto Company, Inc. | Low-calorie food products containing konjak mannan and processes for preparing the same |
US5118673A (en) | 1982-05-07 | 1992-06-02 | Carrington Laboratories, Inc. | Uses of aloe products |
US5147862A (en) | 1989-02-20 | 1992-09-15 | Taito Co., Ltd. | Composition and process to enhance the efficacy of a fish vaccine |
US5158772A (en) | 1991-09-23 | 1992-10-27 | Davis Walter B | Unique bacterial polysaccharide polymer gel in cosmetics, pharmaceuticals and foods |
US5165968A (en) | 1989-08-17 | 1992-11-24 | Hewlett-Packard Company | Ink composition having rapid dry time and high print quality for plain paper printing |
US5167708A (en) | 1991-04-04 | 1992-12-01 | Bayer Aktiengesellschaft | Process for the preparation of pigments containing Cr2 O3 |
US5185327A (en) | 1987-02-20 | 1993-02-09 | Ajinomoto Company, Inc. | Glucan derivatives having tumoricidal activity |
US5189028A (en) | 1989-02-20 | 1993-02-23 | Taito Co., Ltd. | Composition and method to enhance the efficacy of a fish vaccine and to stimulate the immune system of fish |
US5188852A (en) | 1990-02-01 | 1993-02-23 | Oriental Yeast Co., Ltd. | Process for producing yeast extract |
US5191016A (en) | 1990-07-19 | 1993-03-02 | Manssur Yalpani | Functionalized poly(hydroxyalkanoates) and method of manufacturing same |
US5194600A (en) | 1990-03-05 | 1993-03-16 | Royal Institute For The Advancement Of Learning | Genes which participate in β-glucan assembly and use thereof |
EP0515216A3 (en) | 1991-05-24 | 1993-03-31 | Takeda Chemical Industries, Ltd. | Method of purifying beta-1,3-glucans |
US5223491A (en) | 1989-11-09 | 1993-06-29 | Donzis Byron A | Method for revitalizing skin by applying topically water insoluble glucan |
US5250436A (en) | 1984-11-28 | 1993-10-05 | Massachusetts Institute Of Technology | Glucan compositions and process for preparation thereof |
US5273772A (en) | 1991-10-25 | 1993-12-28 | Arco Chemical Technology, L.P. | Food compositions containing esterified alkoxylated polysaccharide fat substitutes |
US5288704A (en) | 1991-01-31 | 1994-02-22 | Farmitalia Carlo Erba S.R.L. | Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent |
US5308838A (en) | 1982-05-07 | 1994-05-03 | Carrington Laboratories, Inc. | Uses of aloe products |
US5314872A (en) | 1988-06-06 | 1994-05-24 | Takeda Chemical Industries, Ltd. | Glucan sulfate, stabilized fibroblast growth factor composition |
US5322841A (en) | 1989-09-08 | 1994-06-21 | Alpha-Beta Technology, Inc. | Method for producing neutral glucans for pharmaceutical applications |
EP0566347A3 (en) | 1992-04-16 | 1994-07-06 | Cpc International Inc | Use of yeast cell debris products |
US5332667A (en) | 1989-02-08 | 1994-07-26 | Sapporo Breweries Limited | Method for producing biologically active polysaccharide RON substance |
US5342626A (en) | 1993-04-27 | 1994-08-30 | Merck & Co., Inc. | Composition and process for gelatin-free soft capsules |
US5358731A (en) | 1987-12-09 | 1994-10-25 | Ajinomoto Co., Inc. | Process for producing konjak mannan containing processed minced meat foods |
US5364462A (en) | 1991-08-14 | 1994-11-15 | Graphic Utilities, Incorporated | Waterfast inks |
US5369029A (en) | 1989-12-01 | 1994-11-29 | Behringwerke Aktiengesellschaft | Method for degrading nucleic acids in waste fermentation solutions with Paecilomyces lilacinus |
US5378232A (en) | 1991-08-28 | 1995-01-03 | Orion Therapeutic Systems, Inc. | Injection/activation apparatus |
US5387427A (en) | 1992-12-30 | 1995-02-07 | Rhone-Poulenc Specialty Chemicals Co. | Inlaid dairy products and processes |
US5387423A (en) | 1992-07-24 | 1995-02-07 | Otsuka Foods Co., Ltd. | Low calorie food material and method of manufacturing the same |
US5401727A (en) | 1990-07-06 | 1995-03-28 | As Biotech-Mackzymal | Process for enhancing the resistance of aquatic animals to disease |
US5422133A (en) | 1992-06-25 | 1995-06-06 | Sugiyo Co., Ltd. | Edible material |
US5428383A (en) | 1992-08-05 | 1995-06-27 | Hewlett-Packard Corporation | Method and apparatus for preventing color bleed in a multi-ink printing system |
US5429828A (en) | 1990-05-29 | 1995-07-04 | Chemgen Corporation | Hemicellulase supplement to improve the energy efficiency of hemicellulose-containing animal feed |
US5447505A (en) | 1993-08-04 | 1995-09-05 | Merocel Corporation | Wound treatment method |
US5449526A (en) | 1992-03-04 | 1995-09-12 | Kabushikikaisha Mannan Ouyou Kaihatsu Kenkyusho | Process for producing dietary fibrous food |
US5458893A (en) | 1992-03-06 | 1995-10-17 | The Quaker Oats Company | Process for treating water-soluble dietary fiber with beta-glucanase |
US5462755A (en) | 1994-03-25 | 1995-10-31 | Kraft Foods, Inc. | Flavor enhancement in cultured dairy products |
US5468510A (en) | 1989-12-11 | 1995-11-21 | Danish Crown Inc. A/S | Low calorie meat products |
US5468737A (en) | 1982-05-07 | 1995-11-21 | Carrington Laboratories, Inc. | Wound healing accelerated by systemic administration of polysaccharide from aloe |
US5480662A (en) | 1993-03-25 | 1996-01-02 | Van Den Bergh Foods Co., Division Of Conopco, Inc. | Fat-reduced laminated doughs |
US5488040A (en) | 1989-09-08 | 1996-01-30 | Alpha-Beta Technology, Inc. | Use of neutral soluble glucan preparations to stimulate platelet production |
US5496544A (en) | 1992-03-05 | 1996-03-05 | L'oreal | Powdered cosmetic composition containing a silicone fatty binder |
US5504079A (en) | 1989-09-08 | 1996-04-02 | Alpha-Beta Technology, Inc. | Method for immune system activation by administration of a β(1-3) glucan which is produced by Saccharomyces cerevisiae strain R4 |
US5506210A (en) | 1988-08-19 | 1996-04-09 | The Australian National University | Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs |
US5512287A (en) | 1994-05-12 | 1996-04-30 | Centennial Foods, Inc. | Production of β-glucan and β-glucan product |
US5519287A (en) | 1994-03-21 | 1996-05-21 | Goodale, Jr.; Garold J. | Two terminal pulsed low voltage incandescent lamp dimmer with increased illuminating efficiency |
US5519009A (en) | 1993-10-01 | 1996-05-21 | Donzis; Byron A. | Solubilized yeast glucan |
US5518710A (en) | 1994-01-11 | 1996-05-21 | University Of Saskatchewan | Methods for extracting cereal β-glucans |
US5523088A (en) | 1994-01-13 | 1996-06-04 | University Of Georgia Research Foundation, Inc. | Inactivated avian polyomavirus vaccine in psittacine birds |
US5543302A (en) | 1988-05-27 | 1996-08-06 | Solvay Enzymes, Inc. | Proteases of altered stability to autolytic degradation |
US5545557A (en) | 1993-04-15 | 1996-08-13 | Cpc International Inc. | Water insoluble coloring agent |
US5554386A (en) | 1986-07-03 | 1996-09-10 | Advanced Magnetics, Inc. | Delivery of therapeutic agents to receptors using polysaccharides |
US5565234A (en) | 1993-06-28 | 1996-10-15 | The Nisshin Oil Mills, Ltd. | Method of producing meat-like protein foods |
US5570015A (en) | 1992-02-05 | 1996-10-29 | Mitsubishi Denki Kabushiki Kaisha | Linear positional displacement detector for detecting linear displacement of a permanent magnet as a change in direction of magnetic sensor unit |
DE3741583C2 (en) | 1986-12-12 | 1996-11-07 | Kemira Oy | Process for the destruction of microbes in the process water of paper mills |
US5574023A (en) | 1991-08-08 | 1996-11-12 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Intramolecularly crosslinked (1→3)-β-D-glucans |
US5576015A (en) | 1995-03-02 | 1996-11-19 | Donzis; Byron A. | Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses |
EP0507952B1 (en) | 1990-09-27 | 1996-12-27 | Seikagaku Kogyo Kabushiki Kaisha | Process for preparing limulus amoebocyte lysate |
US5589591A (en) | 1986-07-03 | 1996-12-31 | Advanced Magnetics, Inc. | Endotoxin-free polysaccharides |
US5595571A (en) | 1994-04-18 | 1997-01-21 | Hancock Jaffe Laboratories | Biological material pre-fixation treatment |
US5599697A (en) | 1992-12-14 | 1997-02-04 | Takeda Chemical Industries, Ltd. | Method of producing β-1,3-glucan |
US5614242A (en) | 1995-09-27 | 1997-03-25 | Barkley Seed, Inc. | Food ingredients derived from viscous barley grain and the process of making |
US5622940A (en) | 1994-07-14 | 1997-04-22 | Alpha-Beta Technology | Inhibition of infection-stimulated oral tissue destruction by β(1,3)-glucan |
US5622939A (en) | 1992-08-21 | 1997-04-22 | Alpha-Beta Technology, Inc. | Glucan preparation |
US5626874A (en) | 1993-11-30 | 1997-05-06 | Ekita Investments N.V. | Controlled release pharmaceutical tablet having lenticular form |
US5663324A (en) | 1989-09-08 | 1997-09-02 | Alpha-Beta Technology, Inc. | Method for producing underivatized, aqueous soluble β(1-3) glucan |
US5681583A (en) | 1993-07-09 | 1997-10-28 | Apr Applied Pharma Research Sa | Multilayered controlled-release oral solid pharmaceutical forms |
US5688931A (en) | 1993-02-26 | 1997-11-18 | Drug Delivery System Institute, Ltd. | Polysaccharide derivatives and drug carriers |
US5690981A (en) | 1988-08-23 | 1997-11-25 | Ajinomoto Co., Inc. | Low calorie foodstuff, aqueous paste composition, as well as production process thereof |
US5695970A (en) | 1992-10-21 | 1997-12-09 | T&M Biopolymer Aktiebolag | Glucan lyase producing 1,5-anhydrofructose |
CA2208896A1 (en) | 1996-06-26 | 1997-12-26 | Robert M. Osburn | Process for producing seeds coated with a microbial composition |
US5712110A (en) | 1987-04-15 | 1998-01-27 | Gist-Brocades, B.V. | Astaxanthin-producing yeast cells methods for their preparation and their use |
US5716652A (en) | 1996-10-02 | 1998-02-10 | Wm. Wrigley Jr. Company | Coated chewing gum products and methods of manufacturing same |
US5718932A (en) | 1995-04-28 | 1998-02-17 | Sugiyo Co., Ltd. | Low-calorie edible material like pate or mousse |
US5747045A (en) | 1994-01-13 | 1998-05-05 | University Of Georgia Research Foundation, Inc. | Avian polyomavirus vaccine in psittacine birds |
US5753266A (en) | 1996-12-03 | 1998-05-19 | Youssefyeh; Parvin | Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases |
US5760702A (en) | 1994-06-10 | 1998-06-02 | Nit Mobile Communications Network Inc. | Receiver with symbol rate sync |
US5773427A (en) | 1996-05-31 | 1998-06-30 | Day; Charles E. | Prevention of fiber-induced intestinal gas production by chitosan |
US5773227A (en) | 1993-06-23 | 1998-06-30 | Molecular Probes, Inc. | Bifunctional chelating polysaccharides |
US5785975A (en) | 1995-06-26 | 1998-07-28 | Research Triangle Pharmaceuticals | Adjuvant compositions and vaccine formulations comprising same |
US5795979A (en) | 1996-06-06 | 1998-08-18 | Ajinomoto Co., Inc. | Water-insoluble glucan purification method |
US5807559A (en) | 1992-04-28 | 1998-09-15 | Astra Aktiebolag | Compositions for generating T cell immunity against carbohydrate structures |
US5827529A (en) | 1991-03-30 | 1998-10-27 | Teikoku Seiyaku Kabushiki Kaisha | External preparation for application to the skin containing lidocaine |
US5827937A (en) | 1995-07-17 | 1998-10-27 | Q Med Ab | Polysaccharide gel composition |
US5861048A (en) | 1994-08-11 | 1999-01-19 | Ezaki Glico Co., Ltd. | Phosphorylated saccharide and method for producing the same |
US5871966A (en) | 1994-05-11 | 1999-02-16 | Novo Nordisk A/S | Enzyme with endo-1,3(4)-β- Glucanase activity |
US5885617A (en) | 1994-07-12 | 1999-03-23 | Bpsi Holdings, Inc. | Moisture barrier film coating composition, method, and coated form |
US5888984A (en) | 1994-05-12 | 1999-03-30 | Dermal Research Laboratories, Inc. | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
US5902607A (en) | 1993-06-30 | 1999-05-11 | De Montfort University | Reversible cross-linked gel |
US5902796A (en) | 1995-09-22 | 1999-05-11 | Carrington Laboratories, Inc. | Bioactive factors of aloe vera plants |
EP0553176B1 (en) | 1990-10-17 | 1999-06-02 | Corn Products International, Inc. | Processing of yeast refuse and resulting product |
US5912153A (en) | 1993-11-18 | 1999-06-15 | Selitrennikoff; Claude P. | (1,3) β-glucan synthase genes and inducible inhibition of fungal growth using the antisense constructs derived therefrom |
US5922118A (en) | 1996-06-14 | 1999-07-13 | Cabot Corporation | Modified colored pigments and ink jet inks, inks, and coatings containing modified colored pigments |
US5932561A (en) | 1997-10-24 | 1999-08-03 | Rexall Sundown, Inc. | Dietary composition with lipid binding properties for weight management and serum lipid reduction |
US5939129A (en) | 1997-02-28 | 1999-08-17 | Kawano; Nobuhisa | Process for production of ground fish meat products or their analogues |
US5955072A (en) | 1994-07-13 | 1999-09-21 | Sankyo Company, Limited | Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide |
US5958755A (en) | 1993-12-01 | 1999-09-28 | Cpc International Inc. | Process of making flavored yeast extracts |
US5972642A (en) | 1987-04-15 | 1999-10-26 | Dsm N.V. | Astaxanthin-producing yeast cells, methods for their preparation and their use |
US5976580A (en) | 1995-06-07 | 1999-11-02 | Novus International, Inc. | Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals |
US5985891A (en) | 1994-12-29 | 1999-11-16 | Rowe; James Baber | Prevention of adverse behavior, diarrhea, skin disorders and infections of the hind gut associated with acidic conditions in humans and animals by the application of antibiotics |
US5989552A (en) | 1993-12-24 | 1999-11-23 | Austin Research Institute | Antigen carbohydrate compounds and their use in immunotherapy |
US6020016A (en) | 1998-04-01 | 2000-02-01 | The J.M. Smucker Company | Glucan containing beverage and method of making the same |
US6020422A (en) | 1996-11-15 | 2000-02-01 | Betzdearborn Inc. | Aqueous dispersion polymers |
US6020324A (en) | 1989-10-20 | 2000-02-01 | The Collaborative Group, Ltd. | Glucan dietary additives |
DE19835767A1 (en) | 1998-08-07 | 2000-02-17 | Kulicke Werner Michael | Process for the production of high-molecular biologically active immunomodulating polysaccharides from yeast Saccharomyces Cerevisiae |
US6036946A (en) | 1997-12-24 | 2000-03-14 | Shaklee Corporation | Methods for protecting skin from damaging effects of ultraviolet light |
US6046323A (en) | 1997-07-29 | 2000-04-04 | The Collaborative Group, Ltd. | Conformations of PPG-glucan |
US6056981A (en) | 1994-02-28 | 2000-05-02 | Biozyme Systems Inc. | Euphausiid harvesting and processing method and apparatus |
US6060429A (en) | 1994-07-25 | 2000-05-09 | State of Israel--Ministry of Agriculture | Composition and method for controlling plant diseases caused by fungi |
US6080222A (en) | 1998-03-02 | 2000-06-27 | Kawamoto; Hidekatsu | Organic liquid nutrition source for plants and manufacturing method for same |
US6080442A (en) | 1997-08-15 | 2000-06-27 | Unitika Ltd. | Mannose-containing feed and process for producing the same |
US6084092A (en) | 1997-01-31 | 2000-07-04 | The Collaborative Group, Ltd. | β(1-3)-glucan diagnostic assays |
US6083547A (en) | 1999-01-14 | 2000-07-04 | Conagra, Inc. | Method for obtaining a high beta-glucan barley fraction |
US6090938A (en) | 1996-05-01 | 2000-07-18 | Collaborative Group, Ltd. | Activation of signal transduction by underivatized, aqueous soluble . .beta(1-3)-Glucan |
US6093552A (en) | 1990-12-03 | 2000-07-25 | Laine; Roger A. | Diagnosis of fungal infections with a chitinase |
US6093426A (en) | 1994-02-01 | 2000-07-25 | Nichirei Corporation | Batter, material for frying, freezing and microwave cooking and frozen fried material for microwave cooking |
US6099876A (en) | 1994-10-11 | 2000-08-08 | Yissum Research Development Co. Of The Hebrew University Of Jerusalem | Temperature-stable liquid cells |
US6110692A (en) | 1996-05-01 | 2000-08-29 | The Collaborative Group, Ltd. | Receptor for underivatized aqueous soluble β(1-3)-glucan |
US6117850A (en) | 1995-08-28 | 2000-09-12 | The Collaborative Group, Ltd. | Mobilization of peripheral blood precursor cells by β(1,3)-glucan |
US6132750A (en) | 1998-04-14 | 2000-10-17 | Coletica | Particles of cross-linked proteins and polysaccharides with hydroxamic groups for chelating metals and their uses notably in cosmetics |
US6143883A (en) | 1998-12-31 | 2000-11-07 | Marlyn Nutraceuticals, Inc. | Water-soluble low molecular weight beta-glucans for modulating immunological responses in mammalian system |
US6143731A (en) | 1989-10-20 | 2000-11-07 | The Collaborative Group, Ltd. | Glucan dietary additives |
US6143551A (en) | 1997-12-29 | 2000-11-07 | Schering Aktiengesellschaft | Delivery of polypeptide-encoding plasmid DNA into the cytosol of macrophages by attenuated listeria suicide bacteria |
US6149940A (en) | 1996-08-29 | 2000-11-21 | Synthelabo | Tablet with controlled release of alfuzosine chlorhydrate |
US6159504A (en) | 1999-01-11 | 2000-12-12 | Kitii Corporation, Ltd. | Core substance-containing calcium microparticles and methods for producing the same |
US6165994A (en) | 1999-02-08 | 2000-12-26 | Blue Ridge Pharmaceuticals, Inc. | Methods for promoting the healing of cutaneous wounds and ulcers using compositions of α-D-glucans |
US6168799B1 (en) | 1997-10-24 | 2001-01-02 | Brennen Medical, Inc. | β-D-glucan topical composition |
JP2001008636A (en) | 1999-06-30 | 2001-01-16 | Tanabe Seiyaku Co Ltd | Feed composition for preventing infectious disease |
US6180159B1 (en) | 1998-01-30 | 2001-01-30 | The Procter & Gamble Company | Beverages with improved texture and flavor impact at lower dosage of solids |
US6194191B1 (en) | 1996-11-20 | 2001-02-27 | Introgen Therapeutics, Inc. | Method for the production and purification of adenoviral vectors |
US6197952B1 (en) | 1996-12-18 | 2001-03-06 | Barkley Seed, Inc. | Long chained beta glucan isolates derived from viscous barley grain, and the process of making |
US6210686B1 (en) | 1998-12-18 | 2001-04-03 | Beth Israel Deaconess Medical Center | Dietary supplement and method for lowering risk of heart disease |
US6210677B1 (en) | 1993-01-29 | 2001-04-03 | Robert C. Bohannon | Method to reduce the physiologic effects of drugs on mammals |
US6214376B1 (en) | 1998-08-25 | 2001-04-10 | Banner Pharmacaps, Inc. | Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture |
US6214337B1 (en) | 1995-04-18 | 2001-04-10 | Biotec Asa | Animal feeds comprising yeast glucan |
US6228391B1 (en) | 1996-05-02 | 2001-05-08 | Terumo Kabushiki Kaisha | Amidine derivatives and drug carriers comprising the same |
US6242594B1 (en) | 1995-03-13 | 2001-06-05 | Novogen Research Pty. Ltd. | Process for glucan preparation and therapeutic uses of glucan |
JP3176418B2 (en) | 1991-06-29 | 2001-06-18 | 日本バイエルアグロケム株式会社 | Agricultural and horticultural fungicides |
US6248566B1 (en) | 1994-09-13 | 2001-06-19 | Ezaki Glico Co., Ltd. | Glucan having cyclic structure and method for producing the same |
US6251877B1 (en) | 1998-03-24 | 2001-06-26 | Pacific Corporation | Composition for external application containing a β-1,6-branched-β-1,3-glucan |
US6254869B1 (en) | 1996-03-27 | 2001-07-03 | The Regents Of The University Of California | Cryptopain vaccines, antibodies, proteins, peptides, DNA and RNA for prophylaxis, treatment and diagnosis and for detection of cryptosporidium species |
US6255291B1 (en) | 1997-03-04 | 2001-07-03 | Peregrine Pharmaceuticals, Inc. | Composition and method for treating cancer and immunological disorders resulting in chronic conditions |
US6271215B1 (en) | 1997-03-11 | 2001-08-07 | The Australian National University | Sulfated oligosaccharides having anticoagulant/antithrombotic activity |
US6280740B1 (en) | 1996-12-20 | 2001-08-28 | Merck & Co., Inc. | Formulations of recombinant papillomavirus vaccines |
US6284509B1 (en) | 1996-04-12 | 2001-09-04 | Novozymes A/S | Enzyme with β-1,3-glucanase activity |
US6284886B1 (en) | 1998-05-27 | 2001-09-04 | Ceapro Inc | Cereal beta glucan compositions and methods of Formulation |
JP3204804B2 (en) | 1993-06-25 | 2001-09-04 | 日本特殊陶業株式会社 | Selective diamond formation |
US6284885B1 (en) | 1997-09-01 | 2001-09-04 | Seikagaku Corporation | Process for preparing (1→3)-β-D-glucan from fungi |
US6287612B1 (en) | 1998-12-01 | 2001-09-11 | Nestec S.A. | Liquid food products and package therefore |
US6291671B1 (en) | 1996-06-06 | 2001-09-18 | Daiichi Pharmaceutical Co., Ltd. | Process for producing drug complexes |
US6306453B1 (en) | 1995-09-05 | 2001-10-23 | Warner-Lambert Company | Anti-stress agents for aquatic animals |
US6323338B1 (en) | 1999-02-17 | 2001-11-27 | Nurture, Inc. | Method for concentrating β-glucan |
US6342486B1 (en) | 1996-07-19 | 2002-01-29 | Mibelle Ag Cosmetics | Polymer glucan ether derivatives, their manufacturing as well as their use |
US6352698B1 (en) | 1996-10-22 | 2002-03-05 | Johnson & Johnson Consumer France, Sas, Roc Division | Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions |
US6355625B1 (en) | 1998-09-14 | 2002-03-12 | Nabi | Compositions of β-glucans and specific IGIV |
US6365176B1 (en) | 2000-08-08 | 2002-04-02 | Functional Foods, Inc. | Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy |
US6365185B1 (en) | 1998-03-26 | 2002-04-02 | University Of Cincinnati | Self-destructing, controlled release peroral drug delivery system |
US6369216B1 (en) | 1998-09-25 | 2002-04-09 | Biopolymer Engineering Pharmaceutical, Inc. | Very high molecular weight β-glucans |
US6379725B1 (en) | 1998-05-05 | 2002-04-30 | Natural Polymer International Corporation | Protein-based chewable pet toy |
US6395314B1 (en) | 1995-01-26 | 2002-05-28 | American Oats, Inc. | Process for forming an oat-based frozen confection |
US6423832B1 (en) | 1997-06-06 | 2002-07-23 | Biotec Pharmacon Asa | Carbohydrates and use thereof |
US6426077B1 (en) | 2000-08-04 | 2002-07-30 | Indoor Tennis Consultants, Inc. | Food product for health, nutrition and weight management |
US6426201B1 (en) | 1996-09-25 | 2002-07-30 | Gracelinc Limited | β-glucan products and extraction processes from cereals |
US20020107226A1 (en) | 1996-04-11 | 2002-08-08 | Vivian Berlin | Assays and reagents for identifying anti-fungal agnets, amd uses related thereto |
US6444448B1 (en) | 1995-07-05 | 2002-09-03 | Carlton And United Breweries, Limited | Production of β-glucan-mannan preparations by autolysis of cells under certain pH, temperature and time conditions |
US6448323B1 (en) | 1999-07-09 | 2002-09-10 | Bpsi Holdings, Inc. | Film coatings and film coating compositions based on polyvinyl alcohol |
EP0664671B1 (en) | 1993-08-06 | 2002-09-11 | Biotec Pharmacon ASA | Animal feeds comprising yeast glucan |
US6455083B1 (en) | 1998-05-05 | 2002-09-24 | Natural Polymer International Corporation | Edible thermoplastic and nutritious pet chew |
US6455090B1 (en) | 1998-07-31 | 2002-09-24 | Ina Food Industry Co., Ltd. | Liquid additive for thickener |
US20020143174A1 (en) | 1998-09-25 | 2002-10-03 | Biopolymer Engineering, Inc. | Very high molecular weight beta-glucans |
US20020146463A1 (en) | 2000-12-16 | 2002-10-10 | Paul Clayton | Health promoting compositions |
US6465218B1 (en) | 1997-04-08 | 2002-10-15 | Japan Applied Microbiology Research Institute Co., Ltd. | Biologically active substance and process of preparing the same |
US6476003B1 (en) | 2000-11-06 | 2002-11-05 | Immusonic, Inc. | Method for preparing small particle size glucan in a dry material |
US6482802B1 (en) | 1998-05-11 | 2002-11-19 | Endowment For Research In Human Biology, Inc. | Use of neomycin for treating angiogenesis-related diseases |
US6482942B1 (en) | 1999-01-12 | 2002-11-19 | Biotechnology Services And Consulting, Inc. | Method of isolating mucilaginous polysaccharides and uses thereof |
US6482632B1 (en) | 1999-03-29 | 2002-11-19 | Council Of Scientic And Industrial Research | Bacteriophage, a process for the isolation thereof, and a universal growth medium useful in the process thereof |
US6486314B1 (en) | 2000-05-25 | 2002-11-26 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Glucan incorporating 4-, 6-, and 4, 6- linked anhydroglucose units |
US6485945B1 (en) | 1999-02-17 | 2002-11-26 | Nurture, Inc. | Polysaccharide compositions and uses thereof |
US6488929B2 (en) | 1994-05-23 | 2002-12-03 | Montana State University | Candida albicans phosphomannan complex as a vaccine |
US6488955B1 (en) | 1996-02-09 | 2002-12-03 | Nestec S.A. | Nutrient composition for exercise |
US20030012819A1 (en) | 2001-01-25 | 2003-01-16 | Ko Thomas S.Y. | Method of preparing biological materials and preparations produced using same |
US6517829B1 (en) | 1998-03-12 | 2003-02-11 | Unilever Patent Holdings Bv | Products comprising inactivated yeasts or moulds provided with active antibodies |
US6531178B2 (en) | 2000-12-08 | 2003-03-11 | Quaker Oats/Rhone-Poulenc Partnership | β-glucan process, additive and food product |
US6534083B2 (en) | 1996-05-08 | 2003-03-18 | Advanced Medical Solutions Limited | Hydrogels |
US20030059416A1 (en) | 1995-06-14 | 2003-03-27 | Erik Slinde | Animal feed |
US6541678B2 (en) | 1999-09-27 | 2003-04-01 | Brennen Medical, Inc. | Immunostimulating coating for surgical devices |
US6548643B1 (en) | 1994-11-16 | 2003-04-15 | Austin Research Institute | Antigen carbohydrate compounds and their use in immunotherapy |
US6548075B1 (en) | 1998-12-28 | 2003-04-15 | Celanese Ventures Gmbh | Cosmetic or medical preparation for topical use |
US6562459B1 (en) | 1998-08-28 | 2003-05-13 | Celanese Ventures Gmbh | Method for the production of spherical microparticles consisting totally or partly of at least one water insoluble polyglucan containing branches and microparticles produced according to said method |
US6566516B1 (en) | 1998-08-31 | 2003-05-20 | Nof Corporation | High purity polysaccharide containing a hydrophobic group and process for producing it |
US6569475B2 (en) | 2000-10-06 | 2003-05-27 | Jae-Mahn Song | Process for mycelial culture using grain |
US6573245B1 (en) | 1998-04-28 | 2003-06-03 | Galenica Pharmaceuticals, Inc. | Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereof |
US6576015B2 (en) | 2000-07-19 | 2003-06-10 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Bone material and collagen combination for repair of injured joints |
US6576307B2 (en) | 1996-11-29 | 2003-06-10 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Inclusion packaged product and preparation of the same |
US20030124597A1 (en) | 2001-03-06 | 2003-07-03 | Ambrose Cheung | Compositions and methods for identifying agents which regulate autolytic processes in bacteria |
US20030130205A1 (en) | 2000-04-12 | 2003-07-10 | Christian Samuel T. | Novel pharmaceutical anti-infective agents containing carbohydrate moieties and methods of their preparation and use |
US6592897B1 (en) | 1998-04-09 | 2003-07-15 | Axiva Gmbh | Slow release tablet prepared from linear water-insoluble polysacchrides |
US6592914B1 (en) | 1998-10-26 | 2003-07-15 | Angeliki Oste Triantafyllou | Method for isolation of a β-glucan composition from oats and products made therefrom |
US6593470B1 (en) | 1998-08-28 | 2003-07-15 | Celanese Ventures Gmbh | Method for the production of small spherical particles containing at least one water-insoluble linear polysaccharide |
US20030153746A1 (en) | 2002-02-04 | 2003-08-14 | Van Lengerich Bernhard H. | Beta-glucan compositions and process therefore |
US6607775B2 (en) | 1998-08-06 | 2003-08-19 | Good Humor-Breyers Ice Cream, Division Of Conopco, Inc. | Frozen low-fat food emulsions |
US20030154974A1 (en) | 2000-02-07 | 2003-08-21 | Morgan Keith Raymond | Process for extraction of beta-glucan from cereals and products obtained therefrom |
US20030165604A1 (en) | 2001-02-15 | 2003-09-04 | Kazufumi Tsubaki | Products containing $g(b)-glucan |
US6635633B2 (en) | 2000-08-14 | 2003-10-21 | Ortho-Pharmaceutical, Inc. | Substituted pyrazoles |
US6635275B1 (en) | 1999-01-29 | 2003-10-21 | Warner-Lambert Company | Modified starch film compositions |
US20030219468A1 (en) | 2002-05-21 | 2003-11-27 | Raczek Nico N. | B-glucan-containing sorbic acid preparation as feed additive in farm animal rearing |
US6656481B1 (en) | 1996-09-06 | 2003-12-02 | Mitsubishi Chemical Corporation | Vaccinal preparations |
US6669975B1 (en) | 2000-02-03 | 2003-12-30 | Mars Incorporated | Customized dietary health maintenance system for pets |
US6669771B2 (en) | 1999-12-08 | 2003-12-30 | National Institute Of Advanced Industrial Science And Technology | Biodegradable resin compositions |
US6673384B1 (en) | 1998-01-30 | 2004-01-06 | The Procter & Gamble Co. | Creamy mouthfeel agent for foods and beverages |
US6677142B1 (en) | 1998-12-28 | 2004-01-13 | Celanese Ventures Gmbh | Polysaccharides containing α-1,4-glucan chains and method for producing same |
US20040014715A1 (en) | 2001-10-09 | 2004-01-22 | Ostroff Gary R. | Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
US20040014320A1 (en) | 2002-07-17 | 2004-01-22 | Applied Materials, Inc. | Method and apparatus of generating PDMAT precursor |
US20040023923A1 (en) | 2000-07-03 | 2004-02-05 | Morgan Keith Raymond | Cold water soluble beta-glucan product and process for preparing the same |
AU2003258181A1 (en) | 2002-08-13 | 2004-02-25 | University Of Louisville Research Foundation Inc. | Methods of using beta glucan as a radioprotective agent |
US6699694B1 (en) | 1998-10-09 | 2004-03-02 | Planttec Biotechnologie Gmbh | Method for producing α-1,6-branched α-1,4-glucans from sucrose |
US6703062B1 (en) | 1998-08-06 | 2004-03-09 | Lipton, Division Of Conopco, Inc. | Low-fat food emulsions having controlled flavor release and processes therefor |
US6706305B2 (en) | 2001-10-31 | 2004-03-16 | Conagra Foods Inc. | Low glycemic index bread |
US20040054166A1 (en) | 2000-08-03 | 2004-03-18 | Martin Sauter | Isolation of glucan particles and uses thereof |
US20040058889A1 (en) | 2002-09-20 | 2004-03-25 | Nino Sorgente | Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption |
US6713450B2 (en) | 2000-05-22 | 2004-03-30 | New York University | Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
US6713459B1 (en) | 2000-04-28 | 2004-03-30 | East Tennessee State University | Methods for the prophylactic and therapeutic treatment of cardiac tissue damage |
JP2004099580A (en) | 2002-09-05 | 2004-04-02 | San Baiorekkusu:Kk | Immunity-reinforcing composition and feed for mammalian animal and fish containing the same |
US6716462B2 (en) | 2000-04-12 | 2004-04-06 | Mid-America Commercialization Corporation | Nutritionally balanced traditional snack foods |
US6720015B2 (en) | 2000-04-12 | 2004-04-13 | Mid-America Commercialization Corporation | Ready-to-eat nutritionally balanced food compositions having superior taste systems |
US6726943B2 (en) | 2000-04-12 | 2004-04-27 | Mid-America Commercialization Corporation | Nutritionally balanced snack food compositions |
US6737089B2 (en) | 1999-08-27 | 2004-05-18 | Morinda, Inc. | Morinda citrifolia (Noni) enhanced animal food product |
US20040116379A1 (en) | 2001-01-16 | 2004-06-17 | Sloan-Kettering Institute For Cancer Research | Therapy-enhancing glucan |
US20040127458A1 (en) | 2000-11-06 | 2004-07-01 | Hunter Kenneth W. | Beta-glucan containing compositions, methods for manufacturing beta-glucans, and for manufacturing and using beta-glucans and conjugates thereof as vaccine adjuvants |
FR2836333B1 (en) | 2002-02-25 | 2004-07-02 | Seppic Sa | PROCESS FOR COLORING DRAGEES, COMPOSITION IMPLEMENTED |
US6797307B2 (en) | 1999-10-13 | 2004-09-28 | Avena Oy | Method for preparing an oat product and a foodstuff enriched in the content of β-glucan |
US6811788B2 (en) | 2000-01-19 | 2004-11-02 | Baofa Yu | Combinations and methods for treating neoplasms |
US6824810B2 (en) | 2002-10-01 | 2004-11-30 | The Procter & Gamble Co. | Creamer compositions and methods of making and using the same |
US6827954B2 (en) | 2000-04-12 | 2004-12-07 | Mid-America Commercialization Corporation | Tasty, convenient, nutritionally balanced food compositions |
US6831173B1 (en) | 1999-02-24 | 2004-12-14 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Process for selective oxidation of primary alcohols and novel carbohydrate aldehydes |
US20040258829A1 (en) | 2003-04-02 | 2004-12-23 | Guo-Hua Zheng | Dietary fiber containing materials comprising low molecular weight glucan |
US6835214B2 (en) | 2001-06-18 | 2004-12-28 | Japan Storage Battery Co., Ltd. | Process for the production of non-aqueous electrolyte battery |
US20050008679A1 (en) | 2003-05-09 | 2005-01-13 | Bedding Peter M.J. | Nutritional product and method for optimizing nutritional uptake in equine foals and other animals |
US6846501B2 (en) | 2000-04-12 | 2005-01-25 | Mid-America Commercialization Corporation | Traditional snacks having balanced nutritional profiles |
US20050020490A1 (en) | 2004-10-18 | 2005-01-27 | Progressive Bioactives Incorporated | A Method of Producing an Economical and Ecologically Sound Natural Immunobiotic Extract for Use as a Health Management Instrument and a Replacement for Growth Promotion Antibiotics in Livestock and Companion Animals. |
US6852333B1 (en) | 1999-03-12 | 2005-02-08 | The Horticulture And Food Research Institute Of New Zealand Limited | Agents and methods for promoting production gains in animals |
US6858244B2 (en) | 2000-04-24 | 2005-02-22 | Ajinomoto Co., Inc. | Seasoning compositions, foods and drinks with the use thereof and processes for producing the same |
US6858214B1 (en) | 1999-03-12 | 2005-02-22 | Biotec Asa | Use of nanoscalar water-soluble β-(1,3) glucans |
US20050058671A1 (en) | 2003-05-09 | 2005-03-17 | Bedding Peter M.J. | Dietary supplement and method for treating digestive system-related disorders |
US20050069989A1 (en) | 2003-09-29 | 2005-03-31 | Kim Jeong Ok | Isoflavone-beta-D-glucan produced by agaricus blazei in the submerged liquid culture and method of producing same |
US6875754B1 (en) | 1999-03-12 | 2005-04-05 | Biotec Asa | Use of water-soluble β-(1,3) glucans as agents for producing therapeutic skin treatment agents |
US6887307B1 (en) | 1999-07-22 | 2005-05-03 | Warner-Lambert Company, Llc | Pullulan film compositions |
US6896918B2 (en) | 2001-04-05 | 2005-05-24 | Fuji Oil Co., Ltd | Mannose-containing palm kernel meal |
US6897046B2 (en) | 1997-04-08 | 2005-05-24 | Japan Applied Microbiology Research Institute Ltd. | Process of preparing biologically active substance |
US6899892B2 (en) | 2001-12-19 | 2005-05-31 | Regents Of The University Of Minnesota | Methods to reduce body fat |
US6899905B2 (en) | 2000-04-12 | 2005-05-31 | Mid-America Commercialization Corporation | Tasty, ready-to-eat, nutritionally balanced food compositions |
US6908885B2 (en) | 2000-05-08 | 2005-06-21 | Suedzucker Aktiengesellschaft Mannheim/Ochsenfurt | Gel comprised of a poly-α-1,4-glucan and starch |
US6919312B2 (en) | 1998-10-28 | 2005-07-19 | Sankyo Co., Ltd. | Bone-pathobolism treating agent |
US20050170062A1 (en) | 2003-10-30 | 2005-08-04 | Hans Burling | Stabilisers useful in low fat spread production |
US6929807B1 (en) | 1996-08-09 | 2005-08-16 | Mannatech, Inc. | Compositions of plant carbohydrates as dietary supplements |
US6936598B2 (en) | 2003-11-21 | 2005-08-30 | Hill's Pet Nutrition, Inc. | Composition and method |
US6939864B1 (en) | 2001-07-09 | 2005-09-06 | Purdue Research Foundation | Animal feed compositions and methods of using the same |
EP1283261B1 (en) | 2000-05-01 | 2008-08-06 | Daiichi Sankyo Company, Limited | Method of screening drug acting on cell wall |
US20080193485A1 (en) | 2005-02-15 | 2008-08-14 | Gorbach Sherwood L | Food Containing a Probiotic and an Isolated Beta-Glucan and Methods of Use Thereof |
US20080194517A1 (en) | 2007-02-09 | 2008-08-14 | L.C.M. Equine Nutraceuticals, Inc. | Equine or canine immunomodulating composition and treatment method |
EP0954978B1 (en) | 1998-03-12 | 2011-11-30 | VHsquared Limited | New products comprising inactivated yeasts or moulds provided with active antibodies |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60196195A (en) * | 1984-03-21 | 1985-10-04 | Dainippon Seito Kk | Preparation of yeast glucan |
FR2726284B1 (en) | 1994-10-31 | 1996-12-27 | Inst Oenologie | BIOLOGICAL PRODUCT FOR THE PHYSICO-CHEMICAL STABILIZATION OF A WINE |
JPH0984529A (en) * | 1995-09-27 | 1997-03-31 | Kohjin Co Ltd | Cattle and poultry feed containing mannan originated from microorganism |
JP2002209598A (en) * | 2001-01-15 | 2002-07-30 | Kirin Brewery Co Ltd | Yeast-originated soluble polysaccharide |
JP2003000197A (en) * | 2001-06-22 | 2003-01-07 | Morinaga & Co Ltd | Composition containing polysaccharide derived from yeast and method for producing the same |
ITCZ20020011A1 (en) * | 2002-12-10 | 2004-06-11 | Antonio Salvatore Pacile | YIELD CERTIFICATION SYSTEM |
DE602004020117D1 (en) | 2004-02-13 | 2009-04-30 | Alpron Co Ltd | PROCESS FOR THE PRODUCTION OF YEAST-GENERIC GLUCAN |
JP2006037016A (en) * | 2004-07-29 | 2006-02-09 | Shiriusu:Kk | METHOD FOR EXTRACTION OF beta-GLUCAN FROM DEER HORN AND GANODERMA LUCIDUM |
JP4570949B2 (en) * | 2004-12-13 | 2010-10-27 | 株式会社アルプロン | Method for producing yeast-derived glucan |
-
2006
- 2006-05-05 US US11/418,922 patent/US20060263415A1/en not_active Abandoned
- 2006-05-05 CA CA2607004A patent/CA2607004C/en active Active
- 2006-05-05 CN CN2006800150267A patent/CN101184780B/en active Active
- 2006-05-05 MX MX2007013725A patent/MX2007013725A/en active IP Right Grant
- 2006-05-05 JP JP2008510230A patent/JP5296531B2/en active Active
- 2006-05-05 EP EP06759096.8A patent/EP1877447B1/en active Active
- 2006-05-05 WO PCT/US2006/017270 patent/WO2006121803A1/en active Application Filing
- 2006-05-05 CA CA2912012A patent/CA2912012C/en active Active
-
2010
- 2010-01-25 US US12/693,164 patent/US8753668B2/en active Active
Patent Citations (448)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1003976A (en) | 1961-02-23 | 1965-09-08 | Kinki Yakult Seizo Kabushiki K | Method of decomposing the cell walls of yeasts with ª‰-glucanase produced by microorganisms |
BE662884A (en) | 1964-04-23 | 1965-10-22 | ||
GB1025139A (en) | 1964-04-23 | 1966-04-06 | Merck Ag E | Dragee and process for the production of dragees |
US3975553A (en) | 1965-03-08 | 1976-08-17 | Henri Griffon | Deproteination of yeast cells |
US3495990A (en) | 1967-03-02 | 1970-02-17 | Pillsbury Co | Aerated food products |
US3754925A (en) | 1970-03-24 | 1973-08-28 | Takeda Chemical Industries Ltd | New thermo gelable polysaccharide containing foodstuffs |
US3822250A (en) | 1970-03-24 | 1974-07-02 | Takeda Chemical Industries Ltd | Thermo-gelable polysaccharide |
US3973008A (en) | 1970-12-30 | 1976-08-03 | Kabushiki Kaisha Shimizu Manzo Shoten | Konjac mannan |
US3880742A (en) | 1972-02-22 | 1975-04-29 | Glaxo Lab Ltd | {62 -1,4,/{62 1,3 Glucanase |
US3943247A (en) | 1972-05-22 | 1976-03-09 | Kaken Kagaku Kabushiki Kaisha | Treatment of bacterial infections with glucan compositions |
US3961080A (en) | 1972-10-17 | 1976-06-01 | Kikkoman Shoyu Co., Ltd. | Process for autolysis of yeast |
US3867554A (en) | 1972-11-29 | 1975-02-18 | Robert William Sucher | Yeast glycan and process of making same |
US3934039A (en) | 1972-11-30 | 1976-01-20 | Societa' Italiana Resine S.P.A. | Process for the production of microorganism lysates |
US4041152A (en) | 1973-07-27 | 1977-08-09 | Charles Chany | Pharmaceutical formulation of interferon insolubilized by fixation on a support |
US4216293A (en) | 1973-10-05 | 1980-08-05 | Laboraton Derivati Organici, S.p.A. | Extracting protease-inhibitor from animal tissue containing same |
US4041181A (en) | 1973-10-18 | 1977-08-09 | Pedigree Petfoods Limited | Pet food and method of making same |
US4016295A (en) | 1973-10-18 | 1977-04-05 | Pedigree Petfoods Limited | Proteinaceous food product |
US4066793A (en) | 1974-03-18 | 1978-01-03 | Ajinomoto Co., Inc. | Seasoning composition and preparation thereof |
GB1502902A (en) | 1974-11-05 | 1978-03-08 | Bayer Ag | Extraction products from material containing or derived from yeast cell walls |
US4122196A (en) | 1974-11-18 | 1978-10-24 | Anheuser-Busch, Incorporated | Process for the manufacture of yeast glycan |
GB1531498A (en) | 1974-11-26 | 1978-11-08 | Takeda Chemical Industries Ltd | Beta-1,3-glucan derivatives |
US4075405A (en) | 1974-11-26 | 1978-02-21 | Takeda Chemical Industries, Ltd. | β-1,3-Glucan derivatives |
US4036993A (en) | 1975-04-25 | 1977-07-19 | Tensei Suisan Company, Limited | Process for preparation of fish meat extracts |
US3989847A (en) | 1975-05-20 | 1976-11-02 | Shinji Kurihara | Process for preparation of seasonings derived from animal meat |
US4207344A (en) | 1975-06-14 | 1980-06-10 | Cerrillo Vincente P | Processes for protecting proteic foodstuffs against spoilage |
US4138479A (en) | 1975-11-07 | 1979-02-06 | Bayer Aktiengesellschaft | Process for the preparation of immunopotentiating agents from components of yeast cell wall material |
US4279653A (en) | 1975-12-05 | 1981-07-21 | Dai Nippon Toryo Co., Ltd. | Ink composition for ink jet recording |
US4072567A (en) | 1975-12-11 | 1978-02-07 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Compound water-insoluble glucan and process for the production thereof |
US4088539A (en) | 1976-05-07 | 1978-05-09 | A. Nattermann & Cie Gmbh | Process of manufacturing enzyme preparation rich in lipase |
US4211645A (en) | 1976-07-16 | 1980-07-08 | Abitibi Paper Company Ltd. | Foam flotation activated sludge process |
US4158607A (en) | 1976-10-19 | 1979-06-19 | Instytut Przemyslu Mleczarskiego | Enzymatic preparation for ripening of milk protein products |
US4454315A (en) | 1976-11-18 | 1984-06-12 | Takeda Chemical Industries, Ltd. | Carboxymethylated derivatives of β-1,3-glucan |
CA1074453A (en) | 1976-11-29 | 1980-03-25 | Arun K. Pandeya | Parallel data processor apparatus |
US4299630A (en) | 1977-04-27 | 1981-11-10 | The Mead Corporation | Infrared absorptive jet printing ink |
US4247541A (en) | 1978-05-12 | 1981-01-27 | Kirin Brewery Company Limited | Ks-2-b |
US4368322A (en) | 1978-06-14 | 1983-01-11 | Anic, S.P.A. | Chitosan-glucan complex, method for its production and end uses |
US4244973A (en) | 1978-06-26 | 1981-01-13 | Lever Brothers Company | Process for producing a detoxified rapeseed protein concentrate |
US4218481A (en) | 1978-10-06 | 1980-08-19 | Standard Oil Company (Indiana) | Yeast autolysis process |
US4295889A (en) | 1978-12-01 | 1981-10-20 | Canon Kabushiki Kaisha | Recording liquid composition |
US4344968A (en) | 1978-12-09 | 1982-08-17 | Nippon Kayaku Kabushiki Kaisha | Pharmaceutical vehicle |
US4303680A (en) | 1979-01-05 | 1981-12-01 | Ajinomoto Company, Incorporated | Production of yeast extract containing flavoring |
US4339360A (en) | 1979-03-31 | 1982-07-13 | Agency Of Industrial Science & Technology | Particles of activated oxidized polysaccharide substance coated with inactive protective layer and method for manufacture thereof |
US4313934A (en) | 1979-05-08 | 1982-02-02 | Kirin Beer Kabushiki Kaisha | Physiologically active polysaccharides, production and uses thereof |
US4340675A (en) | 1979-05-17 | 1982-07-20 | De Forenede Bryggerier A/S | Process for recovering Cu,Zn-superoxide dismutase from yeast |
US4311714A (en) | 1979-06-12 | 1982-01-19 | Endowment And Research Foundation At Montana State University | Production of products from waxy barley grain |
US4247574A (en) | 1979-06-22 | 1981-01-27 | The Calpis Food Industry Co., Ltd. | Method of producing textured protein and textured protein produced thereby |
US4285976A (en) | 1979-11-23 | 1981-08-25 | Standard Oil Company (Indiana) | Method for accelerating autolysis of yeast |
FR2470598B1 (en) | 1979-11-29 | 1984-11-30 | Colorcon | |
US4543370A (en) | 1979-11-29 | 1985-09-24 | Colorcon, Inc. | Dry edible film coating composition, method and coating form |
US4310553A (en) | 1980-02-25 | 1982-01-12 | Odintsova Ekaterina N | Process for producing food vitamin concentrate from wine yeast |
US4381946A (en) | 1980-02-25 | 1983-05-03 | Konishiroku Photo Industry Co., Ltd. | Ink composition for ink-jet recording |
US4311717A (en) | 1980-05-19 | 1982-01-19 | Fmc Corporation | Stabilizing agent for dry mix food products |
US4388115A (en) | 1980-06-13 | 1983-06-14 | Fuji Photo Film Co., Ltd. | Aqueous ink composition |
US4332894A (en) | 1980-08-15 | 1982-06-01 | Purdue Research Foundation | Conversion of guar gum to gel-forming polysaccharides by the action of α-galactosidase |
US4692094A (en) | 1980-11-19 | 1987-09-08 | Messerschmitt-Bolkow-Blohm Gmbh | Rotary positionable installation |
US4361843A (en) | 1981-03-27 | 1982-11-30 | Exxon Research And Engineering Co. | Ink jet compositions and method |
US4383859A (en) | 1981-05-18 | 1983-05-17 | International Business Machines Corporation | Ink jet inks and method of making |
US4508570A (en) | 1981-10-21 | 1985-04-02 | Ricoh Company, Ltd. | Aqueous ink for ink-jet printing |
US4427710A (en) | 1981-12-23 | 1984-01-24 | Nissin Shokuhin Kabushiki Kaisha | Method of manufacturing an instant bean curd or tofu, and the toju made by such method |
US4526794A (en) | 1982-03-08 | 1985-07-02 | General Foods Corporation | Citrus albedo bulking agent and process therefor |
US4477655A (en) | 1982-04-05 | 1984-10-16 | Imperial Chemical Industries Plc | Moulding of poly-hydroxybutyrate containing bacterial cell fragments |
US4587285A (en) | 1982-04-08 | 1986-05-06 | Fritz-Werner Industrie-Ausruestungen Gmbh | Aqueous heat-curable compositions, and their use |
US5441943A (en) | 1982-05-07 | 1995-08-15 | Carrington Laboratories, Inc. | Uses of aloe products |
US5587364A (en) | 1982-05-07 | 1996-12-24 | Carrington Laboratories, Inc. | Uses of aloe products in the treatment of inflammatory diseases |
US5780453A (en) | 1982-05-07 | 1998-07-14 | Carrington Laboratories, Inc. | Uses of aloe products in the treatment of multiple sclerosis |
US5786342A (en) | 1982-05-07 | 1998-07-28 | Carrington Laboratories, Inc. | Uses of aloe products in the treatment of chronic respiratory diseases |
US5118673A (en) | 1982-05-07 | 1992-06-02 | Carrington Laboratories, Inc. | Uses of aloe products |
US5468737A (en) | 1982-05-07 | 1995-11-21 | Carrington Laboratories, Inc. | Wound healing accelerated by systemic administration of polysaccharide from aloe |
US5773425A (en) | 1982-05-07 | 1998-06-30 | Carrington Laboratories, Inc. | Antineoplastic uses of aloe products |
US5308838A (en) | 1982-05-07 | 1994-05-03 | Carrington Laboratories, Inc. | Uses of aloe products |
US5703060A (en) | 1982-05-07 | 1997-12-30 | Carrington Laboratories Inc. | Uses of aloe products in the prevention and treatment of infections and infestations |
US4544552A (en) | 1982-05-28 | 1985-10-01 | Solco Basel Ag | Process for the preparation of cell and tissue regenerating substances |
US4620876A (en) | 1982-08-23 | 1986-11-04 | Ricoh Company, Ltd. | Aqueous ink for ink-jet printing |
US4572832A (en) | 1982-10-07 | 1986-02-25 | Grelan Pharmaceutical Co., Ltd. | Soft buccal |
US4500355A (en) | 1982-10-29 | 1985-02-19 | Ricoh Company, Ltd. | Aqueous ink composition |
US4623624A (en) | 1982-12-30 | 1986-11-18 | Basf Aktiengesellschaft | Isolation of pancreatin |
US4508745A (en) | 1982-12-30 | 1985-04-02 | General Foods Corporation | Production of a mannan oligomer hydrolysate |
US4900571A (en) | 1983-01-28 | 1990-02-13 | Nippon Suisan Kabushiki Kaisha | Process for producing a shark fin analog |
US4584197A (en) | 1983-03-04 | 1986-04-22 | Nihon Bussan Kabushiki Kaisha | Process for preparation of fish and shellfish extracts having pharmaceutical functions |
US4513019A (en) | 1983-07-06 | 1985-04-23 | Seppic | Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions |
US4576646A (en) | 1983-07-06 | 1986-03-18 | Seppic | Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions |
EP0133827B1 (en) | 1983-07-06 | 1988-04-20 | SEPPIC, Société Anonyme dite : | Film forming compositions for the coating of solid forms of pharmaceutical or food products and coated products of these compositions so obtained |
US4692404A (en) | 1983-11-18 | 1987-09-08 | Fujirebio Kabushiki Kaisha | Method of measuring biological ligand by the use of enzymes |
US4707471A (en) | 1983-12-19 | 1987-11-17 | Medicarb Ab | Water-soluble aminated β-1,3-bound D-glucan and composition containing same |
US4588827A (en) | 1984-02-23 | 1986-05-13 | Basf Aktiengesellschaft | Preparation of tetrahydrofuran |
EP0153680B1 (en) | 1984-02-23 | 1989-01-25 | BASF Aktiengesellschaft | Process for the preparation of tetrahydrofuran |
US4484012A (en) | 1984-02-29 | 1984-11-20 | General Foods Corporation | Production of mannitol and higher manno-saccharide alcohols |
US4769363A (en) | 1984-03-08 | 1988-09-06 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Beta-glucan |
US4652455A (en) | 1984-04-19 | 1987-03-24 | Sugiyo Co., Ltd. | Simulated lobster meat and process for preparing same |
US4765992A (en) | 1984-06-01 | 1988-08-23 | Universite De Bordeaux Ii | Stimulation of alcoholic fermentation by adsorption of toxic substances with cell walls |
US4659388A (en) | 1984-06-08 | 1987-04-21 | Daicel Chemical Industries, Ltd. | Additive composition for foods or drugs |
US4804545A (en) | 1984-08-10 | 1989-02-14 | Barco, Inc. | Production of beta-glucan, bran, protein, oil and maltose syrup from waxy barley |
US4795745A (en) | 1984-09-19 | 1989-01-03 | Larm Karl O P | Macrophage-activating composition and a process for its manufacture |
US4737190A (en) | 1984-10-23 | 1988-04-12 | Ricoh Company, Ltd. | Aqueous ink composition for ink-jet recording |
US5506124A (en) | 1984-11-28 | 1996-04-09 | Massachusetts Institute Of Technology | Process for preparing glucanase resistant yeast mutants |
US5250436A (en) | 1984-11-28 | 1993-10-05 | Massachusetts Institute Of Technology | Glucan compositions and process for preparation thereof |
US4992540A (en) | 1984-11-28 | 1991-02-12 | Massachusetts Institute Of Technology | Glucan composition and process for preparation thereof |
US5082936A (en) | 1984-11-28 | 1992-01-21 | Massachusetts Institute Of Technology | Glucan composition and process for preparation thereof |
US5037972A (en) | 1984-11-28 | 1991-08-06 | Massachusetts Institute Of Technology | Glucan composition and process for preparation thereof |
US4810646A (en) | 1984-11-28 | 1989-03-07 | Massachusetts Institute Of Technology | Glucan compositions and process for preparation thereof |
US4749566A (en) | 1984-11-29 | 1988-06-07 | Sanofi | Pharmaceutical composition comprising a combination of at least one immunotoxin and at least one mannose-containing polymer |
US4741907A (en) | 1984-12-17 | 1988-05-03 | Asahi Kasei Kogyo Kabushiki Kaisha | Fresh dough and a method for producing the same |
US4676976A (en) | 1985-03-08 | 1987-06-30 | Ajinomoto Co., Inc. | Konjak mannan-containing reversible gel |
US4806474A (en) | 1985-06-10 | 1989-02-21 | Miles Inc. | Preparation of mycelial chitosan and glucan fractions from microbial biomass |
US4835265A (en) | 1985-06-21 | 1989-05-30 | Consiglio Nazionale Delle Ricerche | Substituted and crosslinked glucans, process and intermediates for preparing them and use thereof |
US4774093A (en) | 1985-06-25 | 1988-09-27 | Fmc Corporation | Polysaccharide compositions, preparation and uses |
US4818751A (en) | 1985-07-02 | 1989-04-04 | Zeria Shinyaku Kogyo Kabushiki Kaisha | Cosmetics |
US4975421A (en) | 1985-08-19 | 1990-12-04 | Bioglucan, Lp. | Soluble phosphorylated glucan: methods and compositions for wound healing |
US4833131A (en) | 1985-08-19 | 1989-05-23 | Bioglucans, L.P. | Soluble phosphorylated glucan: methods and compositions for wound healing |
US4877777A (en) | 1985-08-19 | 1989-10-31 | Bioglucans, L. P. | Soluble phosphorylated glucan |
US4900722A (en) | 1985-08-19 | 1990-02-13 | Bioglucans, L.P. | Methods and compositions for prophylactic and therapeutic treatment of infections |
US4761402A (en) | 1985-08-19 | 1988-08-02 | Bioglucans, L.P. | Methods and compositions for prophylactic and therapeutic treatment of infections |
US4818752A (en) | 1985-08-19 | 1989-04-04 | Bioglucans, L.P. | Soluble phosphorylated glucan: methods and compositions for treatment of neoplastic diseases |
US4739046A (en) | 1985-08-19 | 1988-04-19 | Luzio Nicholas R Di | Soluble phosphorylated glucan |
US4759942A (en) | 1985-09-19 | 1988-07-26 | General Foods Corporation | Process for producing high fiber expanded cereals |
US4882160A (en) | 1985-12-20 | 1989-11-21 | Warner Lambert Co. | Confectionery delivery system for dictary fiber |
US4731248A (en) | 1986-02-18 | 1988-03-15 | Ralston Purina Company | Production of palatability enhancers from the autolysis of filamentous fungi |
US4965347A (en) | 1986-03-03 | 1990-10-23 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Beta-D-glucan, and its production and uses |
US4793860A (en) | 1986-04-02 | 1988-12-27 | Ricoh Company, Ltd. | Aqueous ink composition |
US4810509A (en) | 1986-06-09 | 1989-03-07 | Takeda Chemical Industries, Ltd. | Method for producing yeast extract |
US4795653A (en) | 1986-06-16 | 1989-01-03 | Bommarito Alexander A | Dietary fiber and method of making |
US5589591A (en) | 1986-07-03 | 1996-12-31 | Advanced Magnetics, Inc. | Endotoxin-free polysaccharides |
US5554386A (en) | 1986-07-03 | 1996-09-10 | Advanced Magnetics, Inc. | Delivery of therapeutic agents to receptors using polysaccharides |
US4994285A (en) | 1986-10-22 | 1991-02-19 | Asahi Kasei Kogyo Kabushiki Kaisha | Edible body and process for preparation thereof |
US4981700A (en) | 1986-11-14 | 1991-01-01 | Sarishvili Naskid G | Process for producing sparkling wines |
DE3741583C2 (en) | 1986-12-12 | 1996-11-07 | Kemira Oy | Process for the destruction of microbes in the process water of paper mills |
EP0273000B1 (en) | 1986-12-16 | 1991-09-04 | Warner-Lambert Company | Xylitol coated comestible and method of preparation |
US4808419A (en) | 1987-02-02 | 1989-02-28 | Hsu Edward J | Automated method for a semi-solid fermentation used in the production of ancient quality rice vinegar and/or rice wine |
US5185327A (en) | 1987-02-20 | 1993-02-09 | Ajinomoto Company, Inc. | Glucan derivatives having tumoricidal activity |
US4942540A (en) | 1987-03-02 | 1990-07-17 | Wang Laboratories, Inc. | Method an apparatus for specification of communication parameters |
US4761405A (en) | 1987-03-04 | 1988-08-02 | Nova Pharmaceutical Corporation | Antagonists of specific excitatory amino acid neurotransmitter receptors having increased potency |
US4863746A (en) | 1987-03-05 | 1989-09-05 | Asahi Denka Kogyo Kabushiki Kaisha | Proteinous material |
US5712110A (en) | 1987-04-15 | 1998-01-27 | Gist-Brocades, B.V. | Astaxanthin-producing yeast cells methods for their preparation and their use |
US5972642A (en) | 1987-04-15 | 1999-10-26 | Dsm N.V. | Astaxanthin-producing yeast cells, methods for their preparation and their use |
US4798730A (en) | 1987-06-01 | 1989-01-17 | General Foods Corporation | Hydrolysis of a partially extracted roasted and ground coffee |
US4871571A (en) | 1987-06-30 | 1989-10-03 | Novo Industri A/S | Dietetic foodstuff containing low calorie bulking agent |
US4986999A (en) | 1987-07-20 | 1991-01-22 | Nihon Bussan Kabushiki Kaisha | Anti-denaturation agent for edible paste product |
US4859488A (en) | 1987-09-15 | 1989-08-22 | Kabushiki Kaisha Yakult Honsha | Liquid food for curing constipation: polydextrose and oligosaccharide |
US4876103A (en) | 1987-10-09 | 1989-10-24 | Governor Of Gunma-Ken | Process for making meat products containing a konjac mannan gel |
US5358731A (en) | 1987-12-09 | 1994-10-25 | Ajinomoto Co., Inc. | Process for producing konjak mannan containing processed minced meat foods |
US5089285A (en) | 1987-12-22 | 1992-02-18 | Kabushikikaisha Kibun | Jelly resembling the flesh of fruit |
US4943444A (en) | 1987-12-22 | 1990-07-24 | Kabushikikaisha Kibun | Jelly resembling the flesh of fruit and process for producing the same |
US4948598A (en) | 1988-01-20 | 1990-08-14 | Biodyn Ag | Process for the production of sparkling wine |
US5028703A (en) | 1988-03-11 | 1991-07-02 | Massachusetts Institute Of Technology | Glucan composition and process for preparation thereof |
US5543302A (en) | 1988-05-27 | 1996-08-06 | Solvay Enzymes, Inc. | Proteases of altered stability to autolytic degradation |
US5314872A (en) | 1988-06-06 | 1994-05-24 | Takeda Chemical Industries, Ltd. | Glucan sulfate, stabilized fibroblast growth factor composition |
US4891220A (en) | 1988-07-14 | 1990-01-02 | Immudyne, Inc. | Method and composition for treating hyperlipidemia |
US5506210A (en) | 1988-08-19 | 1996-04-09 | The Australian National University | Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs |
US5690981A (en) | 1988-08-23 | 1997-11-25 | Ajinomoto Co., Inc. | Low calorie foodstuff, aqueous paste composition, as well as production process thereof |
US4962094A (en) | 1988-10-28 | 1990-10-09 | Alpha Beta Technology, Inc. | Glucan dietary additives |
EP0440725B1 (en) | 1988-10-28 | 1994-06-01 | Alpha Beta Technology | Glucan dietary additives |
US5116631A (en) | 1988-12-26 | 1992-05-26 | Ajinomoto Company, Inc. | Low-calorie food products containing konjak mannan and processes for preparing the same |
US4950749A (en) | 1989-01-06 | 1990-08-21 | The Standard Oil Company | Recovery of glucan by employing a divalent cation at an alkaline pH |
US5057503A (en) | 1989-01-23 | 1991-10-15 | The Brigham And Women's Hospital | Derivativized polysaccharides with biologic activity, method of their isolation, and uses therefor |
US5332667A (en) | 1989-02-08 | 1994-07-26 | Sapporo Breweries Limited | Method for producing biologically active polysaccharide RON substance |
US5147862A (en) | 1989-02-20 | 1992-09-15 | Taito Co., Ltd. | Composition and process to enhance the efficacy of a fish vaccine |
US5189028A (en) | 1989-02-20 | 1993-02-23 | Taito Co., Ltd. | Composition and method to enhance the efficacy of a fish vaccine and to stimulate the immune system of fish |
US5084386A (en) | 1989-03-31 | 1992-01-28 | Sri International | Production of beta-1,3-glucan in euglena |
US5008125A (en) | 1989-04-17 | 1991-04-16 | Kraft General Foods, Inc. | Soluble coffee with aroma recovered from the thermal hydrolysis of spent grounds |
US5017224A (en) | 1989-05-10 | 1991-05-21 | Kabushiki Kaisha Pilot | Water-resistant ink composition |
US5032401A (en) | 1989-06-15 | 1991-07-16 | Alpha Beta Technology | Glucan drug delivery system and adjuvant |
US5607677A (en) | 1989-06-15 | 1997-03-04 | Alpha-Beta Technology, Inc. | Glucan drug delivery system and adjuvant |
US5741495A (en) | 1989-06-15 | 1998-04-21 | Alpha-Beta Technology, Inc. | Glucan drug delivery system and adjuvant |
US4978551A (en) | 1989-08-08 | 1990-12-18 | Sugiyo Co., Ltd. | Simulated fish meat and method of producing same |
US5165968A (en) | 1989-08-17 | 1992-11-24 | Hewlett-Packard Company | Ink composition having rapid dry time and high print quality for plain paper printing |
EP0416343A3 (en) | 1989-09-04 | 1991-09-25 | Consiglio Nazionale Delle Ricerche | Process for preparing a glucane-containing product starting from candida albicans bmm-12 |
US5811542A (en) | 1989-09-08 | 1998-09-22 | Alpha-Beta Technology, Inc. | Method for producing soluble glucans |
US5504079A (en) | 1989-09-08 | 1996-04-02 | Alpha-Beta Technology, Inc. | Method for immune system activation by administration of a β(1-3) glucan which is produced by Saccharomyces cerevisiae strain R4 |
US5322841A (en) | 1989-09-08 | 1994-06-21 | Alpha-Beta Technology, Inc. | Method for producing neutral glucans for pharmaceutical applications |
US5488040A (en) | 1989-09-08 | 1996-01-30 | Alpha-Beta Technology, Inc. | Use of neutral soluble glucan preparations to stimulate platelet production |
US5532223A (en) | 1989-09-08 | 1996-07-02 | Alpha-Beta Technology, Inc. | Use of aqueous soluble glucan preparations to stimulate platelet production |
US5849720A (en) | 1989-09-08 | 1998-12-15 | Alpha-Beta Technology, Inc. | Enhancement of non-specific immune defenses by administration of underivatized, aqueous soluble glucans |
US5663324A (en) | 1989-09-08 | 1997-09-02 | Alpha-Beta Technology, Inc. | Method for producing underivatized, aqueous soluble β(1-3) glucan |
US6143731A (en) | 1989-10-20 | 2000-11-07 | The Collaborative Group, Ltd. | Glucan dietary additives |
US6020324A (en) | 1989-10-20 | 2000-02-01 | The Collaborative Group, Ltd. | Glucan dietary additives |
EP0500718B1 (en) | 1989-11-09 | 1997-01-29 | DONZIS, Byron A. | Insoluble yeast extract |
US5223491A (en) | 1989-11-09 | 1993-06-29 | Donzis Byron A | Method for revitalizing skin by applying topically water insoluble glucan |
US5397773A (en) | 1989-11-09 | 1995-03-14 | Donzis; Byron A. | Photoprotective composition containing yeast extract |
CA2072145C (en) | 1989-11-09 | 1997-09-16 | Byron A. Donzis | Insoluble yeast extract |
US5369029A (en) | 1989-12-01 | 1994-11-29 | Behringwerke Aktiengesellschaft | Method for degrading nucleic acids in waste fermentation solutions with Paecilomyces lilacinus |
US5654028A (en) | 1989-12-11 | 1997-08-05 | Slagteriselskabet Wenbo A.M.B.A. | Low calorie meat products |
US5468510A (en) | 1989-12-11 | 1995-11-21 | Danish Crown Inc. A/S | Low calorie meat products |
US5188852A (en) | 1990-02-01 | 1993-02-23 | Oriental Yeast Co., Ltd. | Process for producing yeast extract |
US5194600A (en) | 1990-03-05 | 1993-03-16 | Royal Institute For The Advancement Of Learning | Genes which participate in β-glucan assembly and use thereof |
US5393333A (en) | 1990-03-27 | 1995-02-28 | Societe Anonyme Societe D'exploitation De Produits Pour Les Industries Chimiques S.E.P.P.I.C. | Film-forming product for coating solid forms, process for its manufacture and products coated with this film-forming product |
FR2660317B1 (en) | 1990-03-27 | 1994-01-14 | Seppic | FILM-FORMING PRODUCT FOR COATING SOLID FORMS; ITS MANUFACTURING PROCESS AND PRODUCTS COATED WITH THIS PRODUCT. |
AU7586091A (en) | 1990-03-27 | 1991-10-21 | Societe D'exploitation De Produits Pour Les Industries Chimiques - Seppic | Film-forming product intended for coating solid forms |
USRE38047E1 (en) | 1990-05-29 | 2003-03-25 | Chemgen Corporation | Hemicellulase supplement to improve the energy efficiency of hemicellulose-containing animal feed |
US5429828A (en) | 1990-05-29 | 1995-07-04 | Chemgen Corporation | Hemicellulase supplement to improve the energy efficiency of hemicellulose-containing animal feed |
US5401727A (en) | 1990-07-06 | 1995-03-28 | As Biotech-Mackzymal | Process for enhancing the resistance of aquatic animals to disease |
EP0466037B1 (en) | 1990-07-06 | 1997-12-03 | As Biotec-Mackzymal | Process for preparing a yeast glucan |
US5191016A (en) | 1990-07-19 | 1993-03-02 | Manssur Yalpani | Functionalized poly(hydroxyalkanoates) and method of manufacturing same |
EP0507952B1 (en) | 1990-09-27 | 1996-12-27 | Seikagaku Kogyo Kabushiki Kaisha | Process for preparing limulus amoebocyte lysate |
US5968811A (en) | 1990-10-17 | 1999-10-19 | Cpc International Inc. | Processing of yeast refuse and resulting product |
EP0553176B1 (en) | 1990-10-17 | 1999-06-02 | Corn Products International, Inc. | Processing of yeast refuse and resulting product |
US6093552A (en) | 1990-12-03 | 2000-07-25 | Laine; Roger A. | Diagnosis of fungal infections with a chitinase |
US5288704A (en) | 1991-01-31 | 1994-02-22 | Farmitalia Carlo Erba S.R.L. | Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent |
US5827529A (en) | 1991-03-30 | 1998-10-27 | Teikoku Seiyaku Kabushiki Kaisha | External preparation for application to the skin containing lidocaine |
US5167708A (en) | 1991-04-04 | 1992-12-01 | Bayer Aktiengesellschaft | Process for the preparation of pigments containing Cr2 O3 |
EP0515216A3 (en) | 1991-05-24 | 1993-03-31 | Takeda Chemical Industries, Ltd. | Method of purifying beta-1,3-glucans |
JP3176418B2 (en) | 1991-06-29 | 2001-06-18 | 日本バイエルアグロケム株式会社 | Agricultural and horticultural fungicides |
US5574023A (en) | 1991-08-08 | 1996-11-12 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Intramolecularly crosslinked (1→3)-β-D-glucans |
US5364462A (en) | 1991-08-14 | 1994-11-15 | Graphic Utilities, Incorporated | Waterfast inks |
US5378232A (en) | 1991-08-28 | 1995-01-03 | Orion Therapeutic Systems, Inc. | Injection/activation apparatus |
US5158772A (en) | 1991-09-23 | 1992-10-27 | Davis Walter B | Unique bacterial polysaccharide polymer gel in cosmetics, pharmaceuticals and foods |
US5273772A (en) | 1991-10-25 | 1993-12-28 | Arco Chemical Technology, L.P. | Food compositions containing esterified alkoxylated polysaccharide fat substitutes |
US5570015A (en) | 1992-02-05 | 1996-10-29 | Mitsubishi Denki Kabushiki Kaisha | Linear positional displacement detector for detecting linear displacement of a permanent magnet as a change in direction of magnetic sensor unit |
US5449526A (en) | 1992-03-04 | 1995-09-12 | Kabushikikaisha Mannan Ouyou Kaihatsu Kenkyusho | Process for producing dietary fibrous food |
US5496544A (en) | 1992-03-05 | 1996-03-05 | L'oreal | Powdered cosmetic composition containing a silicone fatty binder |
US5458893A (en) | 1992-03-06 | 1995-10-17 | The Quaker Oats Company | Process for treating water-soluble dietary fiber with beta-glucanase |
US5686296A (en) | 1992-04-16 | 1997-11-11 | Cpc International Inc. | Yeast debris products |
EP0566347A3 (en) | 1992-04-16 | 1994-07-06 | Cpc International Inc | Use of yeast cell debris products |
US6274370B1 (en) | 1992-04-16 | 2001-08-14 | Corn Products International, Inc. | Yeast debris products |
US5807559A (en) | 1992-04-28 | 1998-09-15 | Astra Aktiebolag | Compositions for generating T cell immunity against carbohydrate structures |
US5422133A (en) | 1992-06-25 | 1995-06-06 | Sugiyo Co., Ltd. | Edible material |
US5387423A (en) | 1992-07-24 | 1995-02-07 | Otsuka Foods Co., Ltd. | Low calorie food material and method of manufacturing the same |
US5428383A (en) | 1992-08-05 | 1995-06-27 | Hewlett-Packard Corporation | Method and apparatus for preventing color bleed in a multi-ink printing system |
US5488402A (en) | 1992-08-05 | 1996-01-30 | Hewlett-Packard Company | Method and apparatus for preventing color bleed in a multi-ink printing system |
US20040116380A1 (en) | 1992-08-21 | 2004-06-17 | Spiros Jamas | Underivatized, aqueous soluble beta(1-3) glucan, composition and method of making same |
US5622939A (en) | 1992-08-21 | 1997-04-22 | Alpha-Beta Technology, Inc. | Glucan preparation |
US5817643A (en) | 1992-08-21 | 1998-10-06 | Alpha-Beta Technology, Inc. | Underivatized, aqueous soluable β(1-3) glucan, composition and method of making same |
US5783569A (en) | 1992-08-21 | 1998-07-21 | Alpha-Beta Technology, Inc. | Uses for underivatized, aqueous soluble β(1-3) glucan and compositions comprising same |
US20020032170A1 (en) | 1992-08-21 | 2002-03-14 | Spiros Jamas | Underivatized, aqueous soluble beta (1-3) glucan, composition and method of making same |
US5695970A (en) | 1992-10-21 | 1997-12-09 | T&M Biopolymer Aktiebolag | Glucan lyase producing 1,5-anhydrofructose |
US5599697A (en) | 1992-12-14 | 1997-02-04 | Takeda Chemical Industries, Ltd. | Method of producing β-1,3-glucan |
US5387427A (en) | 1992-12-30 | 1995-02-07 | Rhone-Poulenc Specialty Chemicals Co. | Inlaid dairy products and processes |
US6210677B1 (en) | 1993-01-29 | 2001-04-03 | Robert C. Bohannon | Method to reduce the physiologic effects of drugs on mammals |
US5688931A (en) | 1993-02-26 | 1997-11-18 | Drug Delivery System Institute, Ltd. | Polysaccharide derivatives and drug carriers |
US5480662A (en) | 1993-03-25 | 1996-01-02 | Van Den Bergh Foods Co., Division Of Conopco, Inc. | Fat-reduced laminated doughs |
US5545557A (en) | 1993-04-15 | 1996-08-13 | Cpc International Inc. | Water insoluble coloring agent |
US5342626A (en) | 1993-04-27 | 1994-08-30 | Merck & Co., Inc. | Composition and process for gelatin-free soft capsules |
US5773227A (en) | 1993-06-23 | 1998-06-30 | Molecular Probes, Inc. | Bifunctional chelating polysaccharides |
JP3204804B2 (en) | 1993-06-25 | 2001-09-04 | 日本特殊陶業株式会社 | Selective diamond formation |
US5565234A (en) | 1993-06-28 | 1996-10-15 | The Nisshin Oil Mills, Ltd. | Method of producing meat-like protein foods |
US5902607A (en) | 1993-06-30 | 1999-05-11 | De Montfort University | Reversible cross-linked gel |
US5681583A (en) | 1993-07-09 | 1997-10-28 | Apr Applied Pharma Research Sa | Multilayered controlled-release oral solid pharmaceutical forms |
US5447505A (en) | 1993-08-04 | 1995-09-05 | Merocel Corporation | Wound treatment method |
EP0664671B1 (en) | 1993-08-06 | 2002-09-11 | Biotec Pharmacon ASA | Animal feeds comprising yeast glucan |
US5519009A (en) | 1993-10-01 | 1996-05-21 | Donzis; Byron A. | Solubilized yeast glucan |
US5912153A (en) | 1993-11-18 | 1999-06-15 | Selitrennikoff; Claude P. | (1,3) β-glucan synthase genes and inducible inhibition of fungal growth using the antisense constructs derived therefrom |
US5626874A (en) | 1993-11-30 | 1997-05-06 | Ekita Investments N.V. | Controlled release pharmaceutical tablet having lenticular form |
US5958755A (en) | 1993-12-01 | 1999-09-28 | Cpc International Inc. | Process of making flavored yeast extracts |
US6177256B1 (en) | 1993-12-24 | 2001-01-23 | Austin Research Institute | Antigen carbohydrate compounds and their use in immunotherapy |
US5989552A (en) | 1993-12-24 | 1999-11-23 | Austin Research Institute | Antigen carbohydrate compounds and their use in immunotherapy |
US5518710A (en) | 1994-01-11 | 1996-05-21 | University Of Saskatchewan | Methods for extracting cereal β-glucans |
US5747045A (en) | 1994-01-13 | 1998-05-05 | University Of Georgia Research Foundation, Inc. | Avian polyomavirus vaccine in psittacine birds |
US5523088A (en) | 1994-01-13 | 1996-06-04 | University Of Georgia Research Foundation, Inc. | Inactivated avian polyomavirus vaccine in psittacine birds |
US6093426A (en) | 1994-02-01 | 2000-07-25 | Nichirei Corporation | Batter, material for frying, freezing and microwave cooking and frozen fried material for microwave cooking |
US6056981A (en) | 1994-02-28 | 2000-05-02 | Biozyme Systems Inc. | Euphausiid harvesting and processing method and apparatus |
US5519287A (en) | 1994-03-21 | 1996-05-21 | Goodale, Jr.; Garold J. | Two terminal pulsed low voltage incandescent lamp dimmer with increased illuminating efficiency |
US5462755A (en) | 1994-03-25 | 1995-10-31 | Kraft Foods, Inc. | Flavor enhancement in cultured dairy products |
US5843180A (en) | 1994-04-18 | 1998-12-01 | Hancock Jaffe Laboratories | Method of treating a mammal having a defective heart valve |
US5595571A (en) | 1994-04-18 | 1997-01-21 | Hancock Jaffe Laboratories | Biological material pre-fixation treatment |
US5843181A (en) | 1994-04-18 | 1998-12-01 | Hancock Jaffe Laboratories | Biological material pre-fixation treatment |
US5720777A (en) | 1994-04-18 | 1998-02-24 | Hancock Jaffee Laboratories | Biological material pre-fixation treatment |
US5871966A (en) | 1994-05-11 | 1999-02-16 | Novo Nordisk A/S | Enzyme with endo-1,3(4)-β- Glucanase activity |
US6911436B2 (en) | 1994-05-12 | 2005-06-28 | Dermal Reserach Laboratories, Inc. | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
US5512287A (en) | 1994-05-12 | 1996-04-30 | Centennial Foods, Inc. | Production of β-glucan and β-glucan product |
US5888984A (en) | 1994-05-12 | 1999-03-30 | Dermal Research Laboratories, Inc. | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
US6488929B2 (en) | 1994-05-23 | 2002-12-03 | Montana State University | Candida albicans phosphomannan complex as a vaccine |
US5760702A (en) | 1994-06-10 | 1998-06-02 | Nit Mobile Communications Network Inc. | Receiver with symbol rate sync |
US5885617A (en) | 1994-07-12 | 1999-03-23 | Bpsi Holdings, Inc. | Moisture barrier film coating composition, method, and coated form |
US5955072A (en) | 1994-07-13 | 1999-09-21 | Sankyo Company, Limited | Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide |
US6307038B1 (en) | 1994-07-13 | 2001-10-23 | Sankyo Company, Limited | Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide |
US5622940A (en) | 1994-07-14 | 1997-04-22 | Alpha-Beta Technology | Inhibition of infection-stimulated oral tissue destruction by β(1,3)-glucan |
US6060429A (en) | 1994-07-25 | 2000-05-09 | State of Israel--Ministry of Agriculture | Composition and method for controlling plant diseases caused by fungi |
US5861048A (en) | 1994-08-11 | 1999-01-19 | Ezaki Glico Co., Ltd. | Phosphorylated saccharide and method for producing the same |
US6268182B1 (en) | 1994-08-11 | 2001-07-31 | Ezaki Glico Co., Ltd. | Method and producing phosphorylated saccharides |
US6248566B1 (en) | 1994-09-13 | 2001-06-19 | Ezaki Glico Co., Ltd. | Glucan having cyclic structure and method for producing the same |
US6680184B2 (en) | 1994-10-11 | 2004-01-20 | Yissum Research & Development Co. Of Hebrew University | Encapsulating liquid with hydrocolloid membrane stable from about -20 to 90 degrees C without bursting |
US6099876A (en) | 1994-10-11 | 2000-08-08 | Yissum Research Development Co. Of The Hebrew University Of Jerusalem | Temperature-stable liquid cells |
US6548643B1 (en) | 1994-11-16 | 2003-04-15 | Austin Research Institute | Antigen carbohydrate compounds and their use in immunotherapy |
US5985891A (en) | 1994-12-29 | 1999-11-16 | Rowe; James Baber | Prevention of adverse behavior, diarrhea, skin disorders and infections of the hind gut associated with acidic conditions in humans and animals by the application of antibiotics |
US6395314B1 (en) | 1995-01-26 | 2002-05-28 | American Oats, Inc. | Process for forming an oat-based frozen confection |
US5705184A (en) | 1995-03-02 | 1998-01-06 | Donzis; Byron A. | Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses |
US5576015A (en) | 1995-03-02 | 1996-11-19 | Donzis; Byron A. | Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses |
US5702719A (en) | 1995-03-02 | 1997-12-30 | Donzis; Byron A. | Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses |
US20040082539A1 (en) | 1995-03-13 | 2004-04-29 | Novogen Research Party, Ltd. | Novel therapeutic uses of glucan |
US6242594B1 (en) | 1995-03-13 | 2001-06-05 | Novogen Research Pty. Ltd. | Process for glucan preparation and therapeutic uses of glucan |
US6214337B1 (en) | 1995-04-18 | 2001-04-10 | Biotec Asa | Animal feeds comprising yeast glucan |
US5718932A (en) | 1995-04-28 | 1998-02-17 | Sugiyo Co., Ltd. | Low-calorie edible material like pate or mousse |
US5976580A (en) | 1995-06-07 | 1999-11-02 | Novus International, Inc. | Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals |
US20030059416A1 (en) | 1995-06-14 | 2003-03-27 | Erik Slinde | Animal feed |
US5785975A (en) | 1995-06-26 | 1998-07-28 | Research Triangle Pharmaceuticals | Adjuvant compositions and vaccine formulations comprising same |
US6444448B1 (en) | 1995-07-05 | 2002-09-03 | Carlton And United Breweries, Limited | Production of β-glucan-mannan preparations by autolysis of cells under certain pH, temperature and time conditions |
US5827937A (en) | 1995-07-17 | 1998-10-27 | Q Med Ab | Polysaccharide gel composition |
US6117850A (en) | 1995-08-28 | 2000-09-12 | The Collaborative Group, Ltd. | Mobilization of peripheral blood precursor cells by β(1,3)-glucan |
US6306453B1 (en) | 1995-09-05 | 2001-10-23 | Warner-Lambert Company | Anti-stress agents for aquatic animals |
US5902796A (en) | 1995-09-22 | 1999-05-11 | Carrington Laboratories, Inc. | Bioactive factors of aloe vera plants |
US5725901A (en) | 1995-09-27 | 1998-03-10 | Barkley Seeds, Inc. | Long chained Beta glucan isolates derived from viscous barley grain |
US5614242A (en) | 1995-09-27 | 1997-03-25 | Barkley Seed, Inc. | Food ingredients derived from viscous barley grain and the process of making |
US6488955B1 (en) | 1996-02-09 | 2002-12-03 | Nestec S.A. | Nutrient composition for exercise |
US6254869B1 (en) | 1996-03-27 | 2001-07-03 | The Regents Of The University Of California | Cryptopain vaccines, antibodies, proteins, peptides, DNA and RNA for prophylaxis, treatment and diagnosis and for detection of cryptosporidium species |
US20020107226A1 (en) | 1996-04-11 | 2002-08-08 | Vivian Berlin | Assays and reagents for identifying anti-fungal agnets, amd uses related thereto |
US6284509B1 (en) | 1996-04-12 | 2001-09-04 | Novozymes A/S | Enzyme with β-1,3-glucanase activity |
US6110692A (en) | 1996-05-01 | 2000-08-29 | The Collaborative Group, Ltd. | Receptor for underivatized aqueous soluble β(1-3)-glucan |
US6630310B1 (en) | 1996-05-01 | 2003-10-07 | Biopolymer Engineering Pharmaceutical, Inc. | Assay for binding between carbohydrate and glycolipid |
US6090938A (en) | 1996-05-01 | 2000-07-18 | Collaborative Group, Ltd. | Activation of signal transduction by underivatized, aqueous soluble . .beta(1-3)-Glucan |
US6228391B1 (en) | 1996-05-02 | 2001-05-08 | Terumo Kabushiki Kaisha | Amidine derivatives and drug carriers comprising the same |
US6534083B2 (en) | 1996-05-08 | 2003-03-18 | Advanced Medical Solutions Limited | Hydrogels |
US5773427A (en) | 1996-05-31 | 1998-06-30 | Day; Charles E. | Prevention of fiber-induced intestinal gas production by chitosan |
US5795979A (en) | 1996-06-06 | 1998-08-18 | Ajinomoto Co., Inc. | Water-insoluble glucan purification method |
EP0811690B1 (en) | 1996-06-06 | 2000-01-26 | Ajinomoto Co., Inc. | Water-insoluble glucan purification method |
US6291671B1 (en) | 1996-06-06 | 2001-09-18 | Daiichi Pharmaceutical Co., Ltd. | Process for producing drug complexes |
US5922118A (en) | 1996-06-14 | 1999-07-13 | Cabot Corporation | Modified colored pigments and ink jet inks, inks, and coatings containing modified colored pigments |
CA2208896A1 (en) | 1996-06-26 | 1997-12-26 | Robert M. Osburn | Process for producing seeds coated with a microbial composition |
US6342486B1 (en) | 1996-07-19 | 2002-01-29 | Mibelle Ag Cosmetics | Polymer glucan ether derivatives, their manufacturing as well as their use |
US6929807B1 (en) | 1996-08-09 | 2005-08-16 | Mannatech, Inc. | Compositions of plant carbohydrates as dietary supplements |
US6149940A (en) | 1996-08-29 | 2000-11-21 | Synthelabo | Tablet with controlled release of alfuzosine chlorhydrate |
US6656481B1 (en) | 1996-09-06 | 2003-12-02 | Mitsubishi Chemical Corporation | Vaccinal preparations |
US6426201B1 (en) | 1996-09-25 | 2002-07-30 | Gracelinc Limited | β-glucan products and extraction processes from cereals |
US5716652A (en) | 1996-10-02 | 1998-02-10 | Wm. Wrigley Jr. Company | Coated chewing gum products and methods of manufacturing same |
US6352698B1 (en) | 1996-10-22 | 2002-03-05 | Johnson & Johnson Consumer France, Sas, Roc Division | Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions |
US6020422A (en) | 1996-11-15 | 2000-02-01 | Betzdearborn Inc. | Aqueous dispersion polymers |
US6194191B1 (en) | 1996-11-20 | 2001-02-27 | Introgen Therapeutics, Inc. | Method for the production and purification of adenoviral vectors |
US6576307B2 (en) | 1996-11-29 | 2003-06-10 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Inclusion packaged product and preparation of the same |
US5753266A (en) | 1996-12-03 | 1998-05-19 | Youssefyeh; Parvin | Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases |
US6197952B1 (en) | 1996-12-18 | 2001-03-06 | Barkley Seed, Inc. | Long chained beta glucan isolates derived from viscous barley grain, and the process of making |
US6280740B1 (en) | 1996-12-20 | 2001-08-28 | Merck & Co., Inc. | Formulations of recombinant papillomavirus vaccines |
US6084092A (en) | 1997-01-31 | 2000-07-04 | The Collaborative Group, Ltd. | β(1-3)-glucan diagnostic assays |
US6146684A (en) | 1997-02-28 | 2000-11-14 | Kawano; Nobuhisa | Process for production of ground fish meat products or their analogues |
US5939129A (en) | 1997-02-28 | 1999-08-17 | Kawano; Nobuhisa | Process for production of ground fish meat products or their analogues |
US6255291B1 (en) | 1997-03-04 | 2001-07-03 | Peregrine Pharmaceuticals, Inc. | Composition and method for treating cancer and immunological disorders resulting in chronic conditions |
US6271215B1 (en) | 1997-03-11 | 2001-08-07 | The Australian National University | Sulfated oligosaccharides having anticoagulant/antithrombotic activity |
US6897046B2 (en) | 1997-04-08 | 2005-05-24 | Japan Applied Microbiology Research Institute Ltd. | Process of preparing biologically active substance |
US6465218B1 (en) | 1997-04-08 | 2002-10-15 | Japan Applied Microbiology Research Institute Co., Ltd. | Biologically active substance and process of preparing the same |
US6423832B1 (en) | 1997-06-06 | 2002-07-23 | Biotec Pharmacon Asa | Carbohydrates and use thereof |
US6046323A (en) | 1997-07-29 | 2000-04-04 | The Collaborative Group, Ltd. | Conformations of PPG-glucan |
US6080442A (en) | 1997-08-15 | 2000-06-27 | Unitika Ltd. | Mannose-containing feed and process for producing the same |
US6284885B1 (en) | 1997-09-01 | 2001-09-04 | Seikagaku Corporation | Process for preparing (1→3)-β-D-glucan from fungi |
US5932561A (en) | 1997-10-24 | 1999-08-03 | Rexall Sundown, Inc. | Dietary composition with lipid binding properties for weight management and serum lipid reduction |
US6168799B1 (en) | 1997-10-24 | 2001-01-02 | Brennen Medical, Inc. | β-D-glucan topical composition |
US6036946A (en) | 1997-12-24 | 2000-03-14 | Shaklee Corporation | Methods for protecting skin from damaging effects of ultraviolet light |
US6235272B1 (en) | 1997-12-24 | 2001-05-22 | Shaklee Corporation | Composition for protecting skin from damaging effects of ultraviolet light |
US6143551A (en) | 1997-12-29 | 2000-11-07 | Schering Aktiengesellschaft | Delivery of polypeptide-encoding plasmid DNA into the cytosol of macrophages by attenuated listeria suicide bacteria |
US6673384B1 (en) | 1998-01-30 | 2004-01-06 | The Procter & Gamble Co. | Creamy mouthfeel agent for foods and beverages |
US6180159B1 (en) | 1998-01-30 | 2001-01-30 | The Procter & Gamble Company | Beverages with improved texture and flavor impact at lower dosage of solids |
US6080222A (en) | 1998-03-02 | 2000-06-27 | Kawamoto; Hidekatsu | Organic liquid nutrition source for plants and manufacturing method for same |
EP0954978B1 (en) | 1998-03-12 | 2011-11-30 | VHsquared Limited | New products comprising inactivated yeasts or moulds provided with active antibodies |
US6517829B1 (en) | 1998-03-12 | 2003-02-11 | Unilever Patent Holdings Bv | Products comprising inactivated yeasts or moulds provided with active antibodies |
US6251877B1 (en) | 1998-03-24 | 2001-06-26 | Pacific Corporation | Composition for external application containing a β-1,6-branched-β-1,3-glucan |
US6365185B1 (en) | 1998-03-26 | 2002-04-02 | University Of Cincinnati | Self-destructing, controlled release peroral drug delivery system |
US6020016A (en) | 1998-04-01 | 2000-02-01 | The J.M. Smucker Company | Glucan containing beverage and method of making the same |
US6592897B1 (en) | 1998-04-09 | 2003-07-15 | Axiva Gmbh | Slow release tablet prepared from linear water-insoluble polysacchrides |
US6132750A (en) | 1998-04-14 | 2000-10-17 | Coletica | Particles of cross-linked proteins and polysaccharides with hydroxamic groups for chelating metals and their uses notably in cosmetics |
US6573245B1 (en) | 1998-04-28 | 2003-06-03 | Galenica Pharmaceuticals, Inc. | Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereof |
US6455083B1 (en) | 1998-05-05 | 2002-09-24 | Natural Polymer International Corporation | Edible thermoplastic and nutritious pet chew |
US6379725B1 (en) | 1998-05-05 | 2002-04-30 | Natural Polymer International Corporation | Protein-based chewable pet toy |
US6482802B1 (en) | 1998-05-11 | 2002-11-19 | Endowment For Research In Human Biology, Inc. | Use of neomycin for treating angiogenesis-related diseases |
US6284886B1 (en) | 1998-05-27 | 2001-09-04 | Ceapro Inc | Cereal beta glucan compositions and methods of Formulation |
US6455090B1 (en) | 1998-07-31 | 2002-09-24 | Ina Food Industry Co., Ltd. | Liquid additive for thickener |
US6607775B2 (en) | 1998-08-06 | 2003-08-19 | Good Humor-Breyers Ice Cream, Division Of Conopco, Inc. | Frozen low-fat food emulsions |
US6703062B1 (en) | 1998-08-06 | 2004-03-09 | Lipton, Division Of Conopco, Inc. | Low-fat food emulsions having controlled flavor release and processes therefor |
DE19835767A1 (en) | 1998-08-07 | 2000-02-17 | Kulicke Werner Michael | Process for the production of high-molecular biologically active immunomodulating polysaccharides from yeast Saccharomyces Cerevisiae |
US6214376B1 (en) | 1998-08-25 | 2001-04-10 | Banner Pharmacaps, Inc. | Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture |
US6562459B1 (en) | 1998-08-28 | 2003-05-13 | Celanese Ventures Gmbh | Method for the production of spherical microparticles consisting totally or partly of at least one water insoluble polyglucan containing branches and microparticles produced according to said method |
US6593470B1 (en) | 1998-08-28 | 2003-07-15 | Celanese Ventures Gmbh | Method for the production of small spherical particles containing at least one water-insoluble linear polysaccharide |
US6566516B1 (en) | 1998-08-31 | 2003-05-20 | Nof Corporation | High purity polysaccharide containing a hydrophobic group and process for producing it |
US6355625B1 (en) | 1998-09-14 | 2002-03-12 | Nabi | Compositions of β-glucans and specific IGIV |
US20020143174A1 (en) | 1998-09-25 | 2002-10-03 | Biopolymer Engineering, Inc. | Very high molecular weight beta-glucans |
US6369216B1 (en) | 1998-09-25 | 2002-04-09 | Biopolymer Engineering Pharmaceutical, Inc. | Very high molecular weight β-glucans |
US6699694B1 (en) | 1998-10-09 | 2004-03-02 | Planttec Biotechnologie Gmbh | Method for producing α-1,6-branched α-1,4-glucans from sucrose |
US6592914B1 (en) | 1998-10-26 | 2003-07-15 | Angeliki Oste Triantafyllou | Method for isolation of a β-glucan composition from oats and products made therefrom |
US6919312B2 (en) | 1998-10-28 | 2005-07-19 | Sankyo Co., Ltd. | Bone-pathobolism treating agent |
US6287612B1 (en) | 1998-12-01 | 2001-09-11 | Nestec S.A. | Liquid food products and package therefore |
US6210686B1 (en) | 1998-12-18 | 2001-04-03 | Beth Israel Deaconess Medical Center | Dietary supplement and method for lowering risk of heart disease |
US6677142B1 (en) | 1998-12-28 | 2004-01-13 | Celanese Ventures Gmbh | Polysaccharides containing α-1,4-glucan chains and method for producing same |
US6548075B1 (en) | 1998-12-28 | 2003-04-15 | Celanese Ventures Gmbh | Cosmetic or medical preparation for topical use |
US6143883A (en) | 1998-12-31 | 2000-11-07 | Marlyn Nutraceuticals, Inc. | Water-soluble low molecular weight beta-glucans for modulating immunological responses in mammalian system |
US6159504A (en) | 1999-01-11 | 2000-12-12 | Kitii Corporation, Ltd. | Core substance-containing calcium microparticles and methods for producing the same |
US6482942B1 (en) | 1999-01-12 | 2002-11-19 | Biotechnology Services And Consulting, Inc. | Method of isolating mucilaginous polysaccharides and uses thereof |
US6083547A (en) | 1999-01-14 | 2000-07-04 | Conagra, Inc. | Method for obtaining a high beta-glucan barley fraction |
US6635275B1 (en) | 1999-01-29 | 2003-10-21 | Warner-Lambert Company | Modified starch film compositions |
US6165994A (en) | 1999-02-08 | 2000-12-26 | Blue Ridge Pharmaceuticals, Inc. | Methods for promoting the healing of cutaneous wounds and ulcers using compositions of α-D-glucans |
US6624300B2 (en) | 1999-02-17 | 2003-09-23 | Nurture, Inc. | Method for concentrating beta-glucan film |
US6323338B1 (en) | 1999-02-17 | 2001-11-27 | Nurture, Inc. | Method for concentrating β-glucan |
US6485945B1 (en) | 1999-02-17 | 2002-11-26 | Nurture, Inc. | Polysaccharide compositions and uses thereof |
US6875861B1 (en) | 1999-02-24 | 2005-04-05 | Sca Hygiene Products Zeist B.V. | Process for producing nitrosonium ions |
US6831173B1 (en) | 1999-02-24 | 2004-12-14 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Process for selective oxidation of primary alcohols and novel carbohydrate aldehydes |
US6875754B1 (en) | 1999-03-12 | 2005-04-05 | Biotec Asa | Use of water-soluble β-(1,3) glucans as agents for producing therapeutic skin treatment agents |
US6852333B1 (en) | 1999-03-12 | 2005-02-08 | The Horticulture And Food Research Institute Of New Zealand Limited | Agents and methods for promoting production gains in animals |
US6858214B1 (en) | 1999-03-12 | 2005-02-22 | Biotec Asa | Use of nanoscalar water-soluble β-(1,3) glucans |
US6482632B1 (en) | 1999-03-29 | 2002-11-19 | Council Of Scientic And Industrial Research | Bacteriophage, a process for the isolation thereof, and a universal growth medium useful in the process thereof |
JP2001008636A (en) | 1999-06-30 | 2001-01-16 | Tanabe Seiyaku Co Ltd | Feed composition for preventing infectious disease |
US6448323B1 (en) | 1999-07-09 | 2002-09-10 | Bpsi Holdings, Inc. | Film coatings and film coating compositions based on polyvinyl alcohol |
US6887307B1 (en) | 1999-07-22 | 2005-05-03 | Warner-Lambert Company, Llc | Pullulan film compositions |
US6737089B2 (en) | 1999-08-27 | 2004-05-18 | Morinda, Inc. | Morinda citrifolia (Noni) enhanced animal food product |
US6541678B2 (en) | 1999-09-27 | 2003-04-01 | Brennen Medical, Inc. | Immunostimulating coating for surgical devices |
US6797307B2 (en) | 1999-10-13 | 2004-09-28 | Avena Oy | Method for preparing an oat product and a foodstuff enriched in the content of β-glucan |
US6669771B2 (en) | 1999-12-08 | 2003-12-30 | National Institute Of Advanced Industrial Science And Technology | Biodegradable resin compositions |
US6811788B2 (en) | 2000-01-19 | 2004-11-02 | Baofa Yu | Combinations and methods for treating neoplasms |
US6669975B1 (en) | 2000-02-03 | 2003-12-30 | Mars Incorporated | Customized dietary health maintenance system for pets |
US20030154974A1 (en) | 2000-02-07 | 2003-08-21 | Morgan Keith Raymond | Process for extraction of beta-glucan from cereals and products obtained therefrom |
US6899905B2 (en) | 2000-04-12 | 2005-05-31 | Mid-America Commercialization Corporation | Tasty, ready-to-eat, nutritionally balanced food compositions |
US6720015B2 (en) | 2000-04-12 | 2004-04-13 | Mid-America Commercialization Corporation | Ready-to-eat nutritionally balanced food compositions having superior taste systems |
US6846501B2 (en) | 2000-04-12 | 2005-01-25 | Mid-America Commercialization Corporation | Traditional snacks having balanced nutritional profiles |
US6827954B2 (en) | 2000-04-12 | 2004-12-07 | Mid-America Commercialization Corporation | Tasty, convenient, nutritionally balanced food compositions |
US20030130205A1 (en) | 2000-04-12 | 2003-07-10 | Christian Samuel T. | Novel pharmaceutical anti-infective agents containing carbohydrate moieties and methods of their preparation and use |
US6726943B2 (en) | 2000-04-12 | 2004-04-27 | Mid-America Commercialization Corporation | Nutritionally balanced snack food compositions |
US6716462B2 (en) | 2000-04-12 | 2004-04-06 | Mid-America Commercialization Corporation | Nutritionally balanced traditional snack foods |
US6858244B2 (en) | 2000-04-24 | 2005-02-22 | Ajinomoto Co., Inc. | Seasoning compositions, foods and drinks with the use thereof and processes for producing the same |
US6713459B1 (en) | 2000-04-28 | 2004-03-30 | East Tennessee State University | Methods for the prophylactic and therapeutic treatment of cardiac tissue damage |
EP1283261B1 (en) | 2000-05-01 | 2008-08-06 | Daiichi Sankyo Company, Limited | Method of screening drug acting on cell wall |
US6908885B2 (en) | 2000-05-08 | 2005-06-21 | Suedzucker Aktiengesellschaft Mannheim/Ochsenfurt | Gel comprised of a poly-α-1,4-glucan and starch |
US6713450B2 (en) | 2000-05-22 | 2004-03-30 | New York University | Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
US6486314B1 (en) | 2000-05-25 | 2002-11-26 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Glucan incorporating 4-, 6-, and 4, 6- linked anhydroglucose units |
US20040023923A1 (en) | 2000-07-03 | 2004-02-05 | Morgan Keith Raymond | Cold water soluble beta-glucan product and process for preparing the same |
US6576015B2 (en) | 2000-07-19 | 2003-06-10 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Bone material and collagen combination for repair of injured joints |
US20040054166A1 (en) | 2000-08-03 | 2004-03-18 | Martin Sauter | Isolation of glucan particles and uses thereof |
US6426077B1 (en) | 2000-08-04 | 2002-07-30 | Indoor Tennis Consultants, Inc. | Food product for health, nutrition and weight management |
US6365176B1 (en) | 2000-08-08 | 2002-04-02 | Functional Foods, Inc. | Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy |
US6635633B2 (en) | 2000-08-14 | 2003-10-21 | Ortho-Pharmaceutical, Inc. | Substituted pyrazoles |
US6569475B2 (en) | 2000-10-06 | 2003-05-27 | Jae-Mahn Song | Process for mycelial culture using grain |
US20040127458A1 (en) | 2000-11-06 | 2004-07-01 | Hunter Kenneth W. | Beta-glucan containing compositions, methods for manufacturing beta-glucans, and for manufacturing and using beta-glucans and conjugates thereof as vaccine adjuvants |
US6476003B1 (en) | 2000-11-06 | 2002-11-05 | Immusonic, Inc. | Method for preparing small particle size glucan in a dry material |
US6749885B2 (en) | 2000-12-08 | 2004-06-15 | Quaker Oats/Rhone-Poulenc Partnership | β-Glucan process, additive and food product |
US6531178B2 (en) | 2000-12-08 | 2003-03-11 | Quaker Oats/Rhone-Poulenc Partnership | β-glucan process, additive and food product |
US20020146463A1 (en) | 2000-12-16 | 2002-10-10 | Paul Clayton | Health promoting compositions |
US20040116379A1 (en) | 2001-01-16 | 2004-06-17 | Sloan-Kettering Institute For Cancer Research | Therapy-enhancing glucan |
US20030012819A1 (en) | 2001-01-25 | 2003-01-16 | Ko Thomas S.Y. | Method of preparing biological materials and preparations produced using same |
US20030165604A1 (en) | 2001-02-15 | 2003-09-04 | Kazufumi Tsubaki | Products containing $g(b)-glucan |
US20030124597A1 (en) | 2001-03-06 | 2003-07-03 | Ambrose Cheung | Compositions and methods for identifying agents which regulate autolytic processes in bacteria |
US6896918B2 (en) | 2001-04-05 | 2005-05-24 | Fuji Oil Co., Ltd | Mannose-containing palm kernel meal |
US6835214B2 (en) | 2001-06-18 | 2004-12-28 | Japan Storage Battery Co., Ltd. | Process for the production of non-aqueous electrolyte battery |
US6939864B1 (en) | 2001-07-09 | 2005-09-06 | Purdue Research Foundation | Animal feed compositions and methods of using the same |
US20040014715A1 (en) | 2001-10-09 | 2004-01-22 | Ostroff Gary R. | Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
US6706305B2 (en) | 2001-10-31 | 2004-03-16 | Conagra Foods Inc. | Low glycemic index bread |
US6899892B2 (en) | 2001-12-19 | 2005-05-31 | Regents Of The University Of Minnesota | Methods to reduce body fat |
US20030153746A1 (en) | 2002-02-04 | 2003-08-14 | Van Lengerich Bernhard H. | Beta-glucan compositions and process therefore |
US6835558B2 (en) | 2002-02-04 | 2004-12-28 | General Mills, Inc. | Beta-glucan compositions and process therefore |
FR2836333B1 (en) | 2002-02-25 | 2004-07-02 | Seppic Sa | PROCESS FOR COLORING DRAGEES, COMPOSITION IMPLEMENTED |
EP1480529B1 (en) | 2002-02-25 | 2007-11-14 | Societe D'exploitation De Produits Pour Les Industries Chimiques, S.E.P.P.I.C. | Method of colouring dragees |
US20030219468A1 (en) | 2002-05-21 | 2003-11-27 | Raczek Nico N. | B-glucan-containing sorbic acid preparation as feed additive in farm animal rearing |
US20040014320A1 (en) | 2002-07-17 | 2004-01-22 | Applied Materials, Inc. | Method and apparatus of generating PDMAT precursor |
AU2003258181A1 (en) | 2002-08-13 | 2004-02-25 | University Of Louisville Research Foundation Inc. | Methods of using beta glucan as a radioprotective agent |
JP2004099580A (en) | 2002-09-05 | 2004-04-02 | San Baiorekkusu:Kk | Immunity-reinforcing composition and feed for mammalian animal and fish containing the same |
US20040058889A1 (en) | 2002-09-20 | 2004-03-25 | Nino Sorgente | Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption |
US6824810B2 (en) | 2002-10-01 | 2004-11-30 | The Procter & Gamble Co. | Creamer compositions and methods of making and using the same |
CA2501889A1 (en) | 2002-10-09 | 2005-02-17 | Biopolymer Engineering, Inc. | Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
US20040258829A1 (en) | 2003-04-02 | 2004-12-23 | Guo-Hua Zheng | Dietary fiber containing materials comprising low molecular weight glucan |
US20050008679A1 (en) | 2003-05-09 | 2005-01-13 | Bedding Peter M.J. | Nutritional product and method for optimizing nutritional uptake in equine foals and other animals |
US20050058671A1 (en) | 2003-05-09 | 2005-03-17 | Bedding Peter M.J. | Dietary supplement and method for treating digestive system-related disorders |
US20050069989A1 (en) | 2003-09-29 | 2005-03-31 | Kim Jeong Ok | Isoflavone-beta-D-glucan produced by agaricus blazei in the submerged liquid culture and method of producing same |
US20050170062A1 (en) | 2003-10-30 | 2005-08-04 | Hans Burling | Stabilisers useful in low fat spread production |
US6936598B2 (en) | 2003-11-21 | 2005-08-30 | Hill's Pet Nutrition, Inc. | Composition and method |
US20050020490A1 (en) | 2004-10-18 | 2005-01-27 | Progressive Bioactives Incorporated | A Method of Producing an Economical and Ecologically Sound Natural Immunobiotic Extract for Use as a Health Management Instrument and a Replacement for Growth Promotion Antibiotics in Livestock and Companion Animals. |
US20080193485A1 (en) | 2005-02-15 | 2008-08-14 | Gorbach Sherwood L | Food Containing a Probiotic and an Isolated Beta-Glucan and Methods of Use Thereof |
US20080194517A1 (en) | 2007-02-09 | 2008-08-14 | L.C.M. Equine Nutraceuticals, Inc. | Equine or canine immunomodulating composition and treatment method |
Non-Patent Citations (61)
Title |
---|
Babayan, T.L. et al., "Isolation of physiologically active mannan and other polysaccharides from autolysate of baker's yeast," Biotekhnologiya (1992) 2:23-26. |
Bacon, J.S.D. et al., "The glucan components of the cell wall of baker's yeast (Saccharomyces cerevisiae) considered in relation to its ultrastructure," Biochem. J. (1969) 114:557-567. |
Ballou, C., "Some aspects of the structure, immunochemistry, and genetic control of yeast mannans," Adv. Enzymol. (1974) 40:239-270. |
Ballou, C., "Structure and biosynthesis of the mannan component of the yeast cell envelope," Adv. Microbiol. Physiol. (1976) 14:93-158. |
Behall, K.M. et al., "Effect of beta-glucan level in oat fiber extracts on blood lipids in men and women," J. Amer. Coll. Nutri. (1997) 16(1):46-51. |
Bell, D.J. et al., "The structure of a cell wall of baker's yeast," J. Chem. Soc. (1950) 1944-1947. |
Bonaly, R. et al., "Etude des parois de levures du genre rhodotorula. II. Influence des conditions de culture sur la composition climique des parois," Biochim. Biophys. Acta (1971) 244:484-494. |
Braaten, J.T. et al., "Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects," Eur. J. Clin. Nutri. (1994) 48(7):465-474. |
Cabib, E. et al., "Chitin and yeast budding," J. Biol. Chem. (1971) 246(1):152-159. |
Canadian Patent Office Action for Application No. 2607004 dated Sep. 21, 2012 (2 pages). |
Chinese Patent Office Action for Application No. 200680015026.7 dated Dec. 18, 2009 (11 pages). |
Chinese Patent Office Action for Application No. 200680015026.7 dated Feb. 6, 2012 (4 pages). |
Chinese Patent Office Action for Application No. 200680015026.7 dated Mar. 14, 2011 (5 pages). |
Cid, V.J. et al., "Molecular basis of cell integrity and morphogenesis in Saccharomyces cerevisiae," Microbiol. Reviews (1995) 59:345-386. |
Conway, J. et al., "The effect of the addition of proteases and glucanases during yeast autolysis on the production and properties of yeast extracts," Can. J. Microbiol. (2001) 47(1):18-24 (Abstract). |
European Patent Office Action for Application No. 06759096.8 dated Apr. 23, 2010 (3 pages). |
European Patent Office Action for Application No. 06759096.8 dated May 4, 2012 (6 pages). |
European Patent Office Action for Application No. 06759096.8 dated Nov. 18, 2011 (7 pages). |
Fleet, G.H. et al., "Isolation and composition of an alkali-soluble glucan from the cell walls of Saccharomyces cerevisiae," J. Gen. Microbio. (1976) 94:180-192. |
Freimund, S. et al., "A new non-degrading isolation process for 1,3-beta-d-glucan of high purity from baker's yeast Saccharomyces cerevisiae," Carbohydrate Polymers (2003) 54(2):159-171. |
Hernawan, T. et al., "Chemical and cytological changes during the autolysis of yeasts," J. Indust. Microb. (1995) 14:440-450. |
International Preliminary Report on Patentability and Written Opinion for Application No. PCT/US2006/017270 dated Nov. 15, 2007 (9 pages). |
International Search Report for Application No. PCT/US2006/017270 dated Sep. 25, 2006 (5 pages). |
Jamas et al., "Morphology of yeast cell wall as affected by genetic manipulation of B(1-6) glycosidic linkage," Biotech. Bioengineering (1986) 28:769-784. |
Japanese Patent Office Action for Application No. 2008-510230 dated Nov. 15, 2011 (4 pages). |
Japanese Patent Office Action for Application No. 2008-510230 dated Oct. 30, 2012 (English Translation Only, 2 pages). |
Jung, P. et al., "Identification of the lipid intermediate in yeast mannan biosynthesis," Eur. J. Biochem. (1973) 37:1-6. |
Kath, F. et al., "Mild enzymatic isolation of mannan and glucan from yeast Saccharomyces cerevisiae," Die Angewandte Makromolekulare Chemie (1999) 268(1):59-68 (Abstract). |
Klis, F.M. et al., "Review: Cell wall assembly in yeast," Yeast (1994) 10:851-869. |
Kopecka, M., "Electron microscopic study of purified polysaccharide components glucans and mannan of the cell walls in the yeast Saccharomyces cerevisiae," J. Basic Microbio. (1985) 25(3):161-174. |
Lehninger, A.L., Biochemistry, 2nd Edition, Worth Publishers, Inc., NY (1978) 220-221. |
Lipke, P.N. et al., "Cell wall architecture in yeast: new structure and new challenges," J. Bacter. (1998) 180(15):3735-3740. |
Manners et al., "The structure of a beta-(1->6)-D-glucan from yeast cell walls,"Biochem. J. (1973) 135:31-36. |
Manners et al., "The structure of a β-(1→6)-D-glucan from yeast cell walls,"Biochem. J. (1973) 135:31-36. |
Manners, D.J. et al., "The structure of a beta-(1->3)-D-glucan from yeast cell walls," Biochem. J. (1973) 135:19-30. |
Manners, D.J. et al., "The structure of a β-(1→3)-D-glucan from yeast cell walls," Biochem. J. (1973) 135:19-30. |
Mexican Patent Office Action for Application No. MX/A/2007/013725 dated May 18, 2012 (2 pages) English translation only. |
Mexican Patent Office Action for Application No. MX/a/2007/013725 dated May 20, 2011 (4 pages). |
Mexican Patent Office Action for Application No. MX/A/2007/013725 dated Oct. 17, 2011 (3 pages) English translation only. |
Nakajima, T. et al., "Characterization of the carbohydrate fragments obtained from Saccharomyces cerevisiae mannan by alkaline degradation," J. Biol. Chem. (1974) 249(23):7679-7684. |
Office Action, European Patent Application No. 06759096.8, dated Mar. 18, 2014. |
Okubo, Y. et al., "Relationship between phosphate content and immunochemical properties of subfractions of bakers' yeast mannan," J. Bacteriol. (1978) 136(1):63-68. |
Pastor, F.I.J. et al., "Structure of the Saccharomyces cerevisiae cell wall. Mannoproteins released by zymolyase and their contribution to wall architecture," Biochimica et Biophysica Acta (1984) 802:292-300. |
Peat, S. et al., "Polysaccharides of baker's yeast. Part III. The presence of 1:6-linkages in yeast glucan," J. Chem. Soc. (1958) 3868-3870. |
Peat, S. et al., "Polysaccharides of baker's yeast. Part IV. Mannan." J. Chem. Soc. (1961) 29-34. |
Pelczar et al., Elements of Microbiology, McGraw-Hill, Inc. (1981) 35. |
Phaff, H.J., "Structure and biosynthesis of the yeast cell envelope," The Yeasts, A.H. Rose et al., Eds. (1971) Chapter 5:135-210. |
Sakata et al., "Stimulatory effect of short chain fatty acids on the epithelial cell proliferation in rat large intestine," Comp. Biochem. Phys. (1983) 74A(2):459-462. |
Scaringi, L. et al., "Cell wall components of Candida albicans as immunomodulators: induction of natural killer and machrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions," J. Gen. Microbiol. (1988) 134:1265-1274. |
Schoenherr et al., "Titration of MacroGard-S on growth performance of nursery pigs," J. Animal Science (1994) 72(2):57 Abstract. |
Sentandreau, R. et al., "The characterization of ligosaccharides attached to threonine and serine in a mannan glycopeptide obtained from the cell wall of yeast," Carb. Res. (1969) 10:584-585. |
Sentandreau, R. et al., "The structure of a glycopeptide isolated from the yeast cell wall," Biochem. J. (1968) 109:419-432. |
Shibata, N. et al., "Immunochemical properties of mannan-protein complex isolated from viable cells of Saccharomyces cerevisiae 4484-24D-1 mutant strain by the action of zymolyase," Microbiol. Immunol. (1984) 28(12):1283-1292. |
Singleton, Dictionary of Microbiology & Molecular Biology, John Wiley & Sons Ltd. (1987) 389 and 391. |
U.S. Appl. No. 11/418,922 dated Jul. 23, 2009 (8 pages). |
U.S. Appl. No. 11/418,922 dated Nov. 21, 2008 (6 pages). |
Valentin, E. et al., "Solubilization and analysis of mannoprotein molecules from the cell wall of Saccharomyces cerevisiae," J. Gen. Microbiol. (1984) 130:1419-1428. |
Williams, D.L. et al., "A method for the solubilization of a (1->3)-beta-D-glucan isolated from Saccharomyces cerevisiae," Carb. Res. (1991) 219:203-213. |
Williams, D.L. et al., "A method for the solubilization of a (1→3)-β-D-glucan isolated from Saccharomyces cerevisiae," Carb. Res. (1991) 219:203-213. |
Williams, D.L. et al., "Molecular weight analysis of a water-insoluble, yeast-derived (1->3)-beta-D-glucan by organic-phase size-exclusion chromatography," Carb. Res. (1994) 253:293-298. |
Williams, D.L. et al., "Molecular weight analysis of a water-insoluble, yeast-derived (1→3)-β-D-glucan by organic-phase size-exclusion chromatography," Carb. Res. (1994) 253:293-298. |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10059778B2 (en) | 2014-01-06 | 2018-08-28 | E I Du Pont De Nemours And Company | Production of poly alpha-1,3-glucan films |
US10106626B2 (en) | 2014-01-17 | 2018-10-23 | Ei Du Pont De Nemours And Company | Production of poly alpha-1,3-glucan formate films |
US20170196231A1 (en) * | 2014-06-26 | 2017-07-13 | E I Du Pont De Nemours And Company | Production of poly alpha-1,3-glucan formate food casings |
US10973245B2 (en) * | 2016-06-24 | 2021-04-13 | Yessinergy Holding S/A | Immunomodulatory and growth promoting and controlling composition of intestinal microbiota undesirable bacteria and its use |
US10842809B2 (en) | 2016-12-16 | 2020-11-24 | Hills Pet Nutrition, Inc. | Pet food compositions |
WO2021195605A1 (en) * | 2019-03-27 | 2021-09-30 | West Virginia University | Vaccine formulation to protect against pertussis |
US11701417B2 (en) * | 2019-03-27 | 2023-07-18 | West Virginia University | Vaccine formulation to protect against pertussis |
WO2021209959A2 (en) | 2020-04-17 | 2021-10-21 | Compañia Nacional De Levaduras, Levapan S.A. | Method for obtaining βeta-glucan from baker's yeast |
Also Published As
Publication number | Publication date |
---|---|
EP1877447A1 (en) | 2008-01-16 |
CA2607004A1 (en) | 2006-11-16 |
JP5296531B2 (en) | 2013-09-25 |
CN101184780A (en) | 2008-05-21 |
CN101184780B (en) | 2012-10-03 |
JP2008541700A (en) | 2008-11-27 |
CA2912012C (en) | 2018-05-29 |
WO2006121803A1 (en) | 2006-11-16 |
BRPI0611535A8 (en) | 2017-03-28 |
US20060263415A1 (en) | 2006-11-23 |
MX2007013725A (en) | 2008-04-09 |
EP1877447B1 (en) | 2016-12-21 |
US20100190872A1 (en) | 2010-07-29 |
BRPI0611535A2 (en) | 2010-09-21 |
CA2912012A1 (en) | 2006-11-16 |
CA2607004C (en) | 2016-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8753668B2 (en) | Production of beta-glucans and mannans | |
US9320291B2 (en) | Production of a saccharide composition comprising glucans and mannans by alkaline and acid hydrolysis of yeast cells | |
US9708634B2 (en) | Process for making chitin derivatives | |
US6444448B1 (en) | Production of β-glucan-mannan preparations by autolysis of cells under certain pH, temperature and time conditions | |
EP2272876B1 (en) | Glucan and mannan, their preparation method and use | |
EP3266863B1 (en) | Composition substantially consisting of yeast cell walls and process for the preparation thereof | |
Simpson et al. | Bioprocessing of chitin and chitosan | |
CN100433991C (en) | Method for producing nutrition additive, additive and its use | |
Prieto et al. | An environmental management industrial solution for the treatment and reuse of mussel wastewaters | |
CA2276001C (en) | A method for producing food additive, food additive and the use of it | |
BRPI0611535B1 (en) | METHOD FOR PROCESSING YEAST CELLS TO PRODUCE BETA-GLUCANS AND MANANAS | |
KR20000073415A (en) | Production of chitosan from food wastes or agricultural and livestock farming wastes | |
NZ620188B2 (en) | Process for making chitin derivatives | |
NZ718424B2 (en) | Process for making chitin derivatives | |
Setyahadi | High-Density Chitin–-Chitosan Production and Health Benefits |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SENSIENT FLAVORS INC., INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SEDMAK, JOSEPH JAMES;REEL/FRAME:032721/0898 Effective date: 20061129 Owner name: SENSIENT FLAVORS LLC, INDIANA Free format text: CHANGE OF NAME;ASSIGNOR:SENSIENT FLAVORS INC.;REEL/FRAME:032724/0665 Effective date: 20071217 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551) Year of fee payment: 4 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |